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Cardiovascular diseases (CVDs) are the number one killer worldwide. In 2012, 17.5 million 
people died from CVDs, being responsible for 31% of all the global deaths. Particularly, 42% 
of these CVD deaths are due to coronary artery disease (CAD) [1]. Acute coronary syndrome 
(ACS), as the first common clinical manifestation of CAD, is most often triggered by the 
rupture of the vulnerable atherosclerotic plaque and thrombosis [2-4]. A Vulnerable 
atherosclerotic plaque comprises a lipid-rich necrotic core, covered by thin fibrous cap, that is 
weakened by the macrophages infiltration [5] (fig.1.1). Plaques that have this morphology and 
composition have a larger probability to be associated with acute coronary syndromes in 
clinical studies [6, 7]. To treat the coronary heart disease, percutaneous coronary intervention 
(PCI) may be suggested. It is a non-surgical procedure to open the narrow or blocked arteries 
and restores blood flow to the heart muscle. The procedure is done by inserting a thin catheter 
from the femoral or radial artery to the lesion site in the coronary arteries. At the lesion site, 
the artery is opened up by inflation of a balloon. Stents or scaffolds would be placed to hold 
the artery open. To guide PCI, an imaging technique capable of directly visualizing the 
vulnerable plaque lesion is very desirable.  
 
 
Figure 1.1 (a) Illustration of rupture of the vulnerable plaque. (b) The main composition of a vulnerable plaque 
 
1.1 Intravascular imaging techniques 
In the past three decades, several imaging modalities have been employed to identify 
vulnerable plaques. Coronary angiography is the oldest of these modalities and can only 
visualize the artery lumen not the artery wall and atherosclerotic lesions. Moreover, 
angiography images a 3D moving object in a 2D presentation.  
Intravascular, catheter-based imaging methods can be safely used in a routine catheterization 
laboratory population [8] and offer direct visualization of the artery wall. Intravascular 
ultrasound (IVUS) imaging has been used in routine clinical practice for more than 20 years. 
Due to the limited acoustic contrast between soft tissues, the conventional greyscale IVUS 
image is not sensitive enough to differentiate plaque composition (except for calcium) [9, 10]. 
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While an advanced analysis algorithm applied to IVUS images –VH-IVUS – has been 
developed to improve the plaque composition characterization[11], no data yet support its 
accuracy[12-14] to detect a lipid-rich necrotic plaque core. IVUS palpography is a technology 
to assess the local mechanical plaque properties based on the tissue deformation caused by the 
intraluminal pressure[15]. However, it can only sense the stiffness of the tissue rather than 
image the tissue, and assesses only the first 450 µm of the arterial wall [15].  
Light-based intravascular optical coherence tomography (IVOCT) makes high resolution 
images (approx. 15 µm) with backscattered light from the tissue [16] and can image plaque 
components such as calcium, lipid, and thrombus. However, IVOCT currently relies on 
qualitative image interpretation to distinguish these features [17, 18]. The penetration depth of 
IVOCT is limited to 1–2 mm into atherosclerotic tissue, which means it often cannot see the 
extent of the plaque up to the adventitia.  
Near-infrared spectroscopy (NIRS) is another light-based imaging modality for detection of 
lipid-rich necrotic core in plaque[19]. It provides a probability for the presence of coronary 
lipid based on spectral analysis of backscattered light[20]. However, NIRS cannot identify the 
amount and location of lipids, which may be important in risk assessment [21].  
Several other innovative optical modalities have been proposed recently [22-25] and are 
currently being evaluated in clinical trials. The ability of these technologies to provide reliable, 
spatially precise, quantitative imaging of plaque lipid content is yet to be realized. We review 
one newer modality: intravascular photoacoustic (IVPA) imaging, an optical-acoustic hybrid 
imaging modality. 
IVPA is currently under development to meet the needs of showing both morphology and 
chemical composition of the artery wall with good imaging depth and resolution. This 
technology takes advantages of the unique optical absorption contrast between different tissues 
and reasonably large penetration depth owing to the low acoustic attenuation in soft tissues 
[26, 27]. Published experimental data suggest it may be a strong contender for detailed plaque 
characterization and identification of plaque at increased risk of causing clinical sequelae.  
 1.2 Principles of IVPA imaging of atherosclerotic plaque 
IVPA imaging requires short laser pulses (with a duration of a few nanoseconds) be applied 
for the irradiation of the artery wall. Absorption of the light transfers the optical energy to heat 
in the tissue and causes a thermoelastic expansion leading to a transient pressure rise (the laser 
pulse duration is shorter than both the stress relaxation and the thermal diffusion times). The 
initial pressure rise works as an acoustic source generating a broadband ultrasound wave that 
can be received by an ultrasound transducer. The amplitude of the emitted ultrasound signal is 
proportional to the magnitude of the specific optical absorption of the tissue and the light 
fluence. The time-of-flight of the received IVPA signal is related to the distance between the 
transducer and photoacoustic (PA) source. By illuminating tissue at different wavelengths, 
IVPA imaging is capable to image different tissue compositions based on their spectral 
contrast. Moreover, a co-registered pulse-echo IVUS image is naturally generated with the 
IVPA image, using the same transducer. A simple illustration of the IVPA principle is shown 
Chapter 1. General Introduction 
8 
in Figure 1.2. Combined IVPA/IVUS imaging provides the structure and chemical composition 
of the plaque, which are considered factors for plaque vulnerability.  
 
 
 
 
 
 
 
 
The specific optical absorption spectra of lipids and other pure substances can be related to 
identification of plaque [28]. Various biomarkers present in plaques have been explored for 
their usefulness in IVPA imaging, with lipid being the most used. The capability of IVPA 
imaging of atherosclerotic plaque lipids has been demonstrated extensively with ex vivo tissues 
and in vivo animal models [29-35]. NIRS also makes use of lipid to identify potentially 
vulnerable plaque but with no depth resolution.  
Macrophages are an important cell type related to the progression of atherosclerosis [29] and 
specific imaging of plaque macrophage content is a potentially interesting feature for 
identifying vulnerable plaque [30]. However, macrophages do not exhibit strong intrinsic 
contrast in the way lipids do. Thus, exogenous imaging contrast agents with high optical 
absorption are applied for visualization of macrophages by IVPA imaging [31, 32]. 
Furthermore, given that the activity of the enzyme matrix metalloproteinase (MMP) is an 
indicator of plaque instability, localization of MMP activity with an MMP-sensitive activatable 
probe in vulnerable plaques in human carotid specimens has been achieved using photoacoustic 
imaging [33]. More recently, an ApoE-/- mouse in vivo model injected with a photoacoustic 
ICG@PEG-Ag2S nanoprobe was successful in imaging plaque [34].  
1.3 Challenges to bring IVPA Imaging into Clinical use 
Encouraged by the capability of IVPA imaging of vulnerable atherosclerotic plaque, an 
intensive research effort is ongoing towards translation of IVPA imaging to clinical 
applications. Here, we review some of the key challenges. 
1.3.1 Challenges towards a Miniature IVPA Catheter  
A miniature, highly sensitive and flexible catheter for IVPA imaging is an essential element of 
bringing IVPA imaging technology into common use. As IVPA is an intrinsically multimodal 
imaging technique, the technical requirements on the catheter are more difficult to meet than 
for single-modality probes like OCT or IVUS catheters. A typical IVPA imaging catheter 
catheter 
coronary artery 
Laser irradiation 
  
Light absorption and thermoelastic 
expansion. (Green target has higher 
optical absorption than red one for 
the incident light)  
0 time 
Received IVPA signal: 
PA amplitude from green 
is higher than red due to 
the higher optical 
absorption 
Ultrasound signal 
generation (black 
arc)  
Figure 1.2. Illustration of the IVPA imaging principle. 
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consists of: (a) an optical part for light delivery; and (b) a broadband ultrasound transducer. 
The variety in the arrangement of these two parts in a catheter makes different catheter design. 
Two typical IVPA catheter designs so far are shown in Figure 1.3. The unit shown in Figure 
1.3(a) is a collinear design, providing the largest overlap between optical and acoustic beams. 
Thus the design offers the highest reported sensitivity, but miniaturization is challenging [35, 
36].  
Another design possibility incorporates an offset between optical fiber and ultrasound 
transducer, either longitudinally [37] (see Figure 1.3 (b)) or laterally [38].  This catheter design 
is favored for miniaturization, and thus is most commonly used in many studies. However, the 
impact of the dual beam offset on PA imaging capability is unclear yet. A comprehensive 
characterization of the PA imaging property based on the catheter design is very important for 
better interpretations of the received PA images as well as making improvements for a better 
catheter design.   
 
Figure 1.3. Schematic of different IVPA catheter design. (a) Schematic of a collinear IVPA catheter design. (b) Schematic of 
IVPA catheter with a longitudinal offset between optical and acoustic beams (Red optical beam and green ultrasound beam).  
 1.3.2 Challenge towards Specific Plaque lipids Identification by IVPA Imaging 
IVPA imaging of an atherosclerotic artery, strong PA signal can be generated from the lipids 
in the plaque inside the artery wall as well as in peri-adventitial fat tissue around the artery 
[39]. Fig. 1.4 shows a typical example of IVPA image of an atherosclerotic coronary artery. In 
the IVPA image (fig.1.4 (a)), bright PA signal was clearly visible both in the plaque inside the 
artery wall (3 o’clock to 6 o’ clock and 10 o’clock to 12 o’clock directions) and in the peri-
adventitial fat tissue around the artery wall. While peri-adventitial fat is distributed around 
arteries throughout the body [40], making the detected bright PA signal from it a “false alarm” 
for identifying lipid-rich plaque lesions. Notably, lipids in the plaque lesions are rich in 
cholesterol and cholesteryl esters [41, 42], and the lipids in peri-adventitial fat are stored as a 
mixture of fatty acids [43]. This difference makes it possible to differentiate between them. 
This differentiation allows us to visualize only the plaque lipids while excluding the normal 
peri-adventitial fat. As a consequence, the presence and location of the lipid-rich plaque can be 
reliably and rapidly displayed in vessel cross-sections and longitudinal sections, without 
tedious examination of every individual cross sectional image in a catheter pullback scanning 
or error-prone automated IVUS image processing. This unique specific plaque lipids 
identification would be a valuable tool for guiding the assessment and treatment of coronary 
disease.  
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Figure 1.4 IVPA/US image of an atherosclerotic coronary artery. (a) Merged IVPA (at 1205 nm) and IVUS image of an 
atherosclerotic coronary artery. (b) ) Oil Red O (ORO) histology staining result of the artery sample. In ORO staining, the 
lipids are in red. 
Owing to the spectra contrast between the plaque lipids and peri-adventitial fat, multiple 
wavelength spectroscopic IVPA (sIVPA) imaging is capable of differentiation between them. 
However, performing multiple wavelengths sIVPA imaging impacts the complexity, cost, and 
speed of the imaging system. Minimization of the number of wavelengths for differentiation 
of different lipids, or improving the efficiency for specific lipid differentiation is necessary for 
practical application.  
1.3.3 Challenges towards fast and safe IVPA imaging of vulnerable plaque 
Despite successful plaque identification by IVPA imaging, the low imaging speed severely 
limits its application, mainly due to the slow laser systems being used, which have a pulse 
frequency of about 10-50 Hz. Generally, with a single-element catheter for IVPA imaging, 
every image line requires a laser pulse. To speed up IVPA imaging, a laser system with fast 
pulse rate is necessary. With the introduction of higher pulse-rate laser systems (2 kHz), IVPA 
imaging of lipid depositions has been increased to a speed of 1 frame per second (fps) [35, 36, 
44]. This represents a significant step forward, but is still not fast enough for practical 
application.  
Nevertheless, it is not possible to increase the pulse rate of lase unlimitedly due to the safety 
concern safety concerns about thermal damage of the artery for the patient and potential 
exposure hazard of skin and eyes for the operator. Especially, it is required to maintain enough 
pulse energy for high PA SNR while increasing pulse rate of the laser system for fast imaging 
speed.   
1.4 Thesis objective and outline 
To overcome some challenges addressed above and accelerate the translation of IVPA imaging 
system to clinical application, we are developing a new real-time IVPA imaging system with 
a well characterized, miniature, and flexible catheter, which allows us of the in vivo IVPA 
plaque detection in animal model.   
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Chapter 2 quantifies the imaging properties of a miniature IVPA catheter based on the 
longitudinal dual beam offset catheter design in terms of the spatial resolution. The impact of 
the dual beam offset on the received PA and US images is well characterized. 
Chapter 3 presents an economic algorithm to detect and differentiate between the plaque lipids 
and peri-adventitial fat with only two wavelengths at 1700 nm spectral range. The performance 
of the algorithm was tested in several human coronary artery samples ex vivo.  
Chapter 4 reports the frequency contents of the PA signal generated from the plaque lesion. 
Such information is very helpful to highly increase PA sensitivity for IVPA imaging of plaque 
lesions, enabling the possibility of IVPA imaging of lipids with a low the laser power. 
Chapter 5 demonstrates a new real-time IVPA/US imaging system with a miniature, flexible 
catheter, capable of IVPA/US imaging of lipid plaque at a speed of 20 frames per second. The 
capability of the real-time IVPA/US imaging system was validated on a human atherosclerotic 
coronary ex vivo. With the imaging system, we conducted the first in vivo IVPA/US imaging 
of atherosclerotic plaque on swine coronary artery. 
Chapter 6 concludes the achieved work in this thesis and discuss about some remaining issues 
for the future work.  
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Abstract  
A basic requirement for intravascular photoacoustic (IVPA) imaging catheters is the delivery 
of light lies within the ultrasonic field of view. Size and manufacturing constraints favor probe 
designs with offset optical and acoustic beams. This non-collinear dual beam arrangement 
leads to a curved PA point spread function (PSF). In this work, we characterize the three-
dimensional shape of the PSF for IVPA imaging in clear and optically scattering media. We 
show that the product of the two beam profiles can accurately model the measured peak 
response in clear and scattering media. We discuss the impact of the PSF shape and its relation 
to probe construction. We test imaging capability of the catheter on a phantom and a human 
artery ex vivo. 
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2. 1 Introduction 
Acute events following atherosclerotic plaque rupture such as myocardial infarction and stroke 
are the leading causes of death and disability in the developed world [1]. Plaques prone to 
rupture are known as vulnerable plaques, which are generally characterized by a lipid-rich 
necrotic core with an overlying thin fibrous cap infiltrated by macrophages [2, 3]. The 
vulnerability of an atherosclerotic plaque is associated with the morphology and composition 
of the plaque [4]. Thus, development of coronary imaging modalities to detect structural and 
compositional plaque characteristics has been the subject of intensive preclinical and clinical 
research [5]. 
Intravascular photoacoustic (IVPA) imaging, a catheter-based optical-acoustic hybrid modality, 
has the potential to image atherosclerotic plaques in unprecedented chemical detail. Absorption 
of a short light pulse in tissue generates an ultrasound wave that can be detected by a transducer. 
This makes it possible to image the vessel wall anatomy, employing the chemical specificity 
of the optical absorption spectra to identify different tissue types. By selecting the excitation 
wavelength, various tissue types inside the vessel wall can be characterized. Several recent 
studies [6-11] have shown promising applications of IVPA imaging. Especially, the capability 
of spectroscopic IVPA (sIVPA) to detect lipid content in human coronary atherosclerotic 
arteries ex vivo has been demonstrated [12, 13]. Successful in vivo IVPA imaging of lipids in 
an abdominal aorta of a Watanabe heritable hyperlipidemic (WHHL) -rabbit aorta has also 
been presented recently [14].  
Several design decisions affect the performance of catheters for IVPA imaging, and other forms 
of photoacoustic endoscopy as well [15]. In this work, we assume that an IVPA catheter must 
also be capable of intravascular ultrasound (IVUS) imaging, to provide a conventional pulse-
echo image of tissue structure, to complement a photoacoustic image of tissue composition. 
An integrated IVUS/IVPA catheter normally consists of a broadband ultrasonic transducer, 
which can transmit and receive acoustic waves, and an optical port to deliver the laser light to 
illuminate the vessel wall. Various designs of integrated US/PA endoscopes, either all optical 
[16] or piezoelectric material based [17-21], have been proposed. The smallest catheter 
reported to date is 1.1 mm in diameter, and uses focused illumination for optical-resolution PA 
imaging [22]. 
In PA imaging, the received PA signal V(r) from a source at position r can be written as
h(r) rprV  )( )( 0 , where denotes convolution, h(r) is the transducer spatial impulse response 
and  )(0 rp is the source pressure [23]. The spatial impulse response h(r) of the transducer can 
be obtained by a hydrophone measurement of the transmitted beam profile, and the source 
pressure can be expressed as )( )(0 rFrp a , where  is Grueneisen parameter (dimensionless), 
a  (cm-1) is the absorption coefficient of tissue and )(rF is the laser fluence [24].  The relative 
arrangement of optical fiber and ultrasound element has an impact on the imaging 
characteristics of the probe. If both beams are collinear, the PA and US point spread functions 
(PSFs) will overlap, though not necessarily coincide. Other designs, either longitudinally [11, 
19] or laterally offset [17], are more suitable for miniaturization, but present a more complex 
structure of the PSF in space. Because of the offset between the optical and acoustic beams, 
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the PA imaging plane is curved and the longitudinal and lateral resolutions are affected by the 
beam overlap. The presence of optical scattering by tissue or blood broadens the optical beam, 
and thus should reduce the curvature. 
In this paper, we study the effect of the catheter tip geometry on imaging by quantifying the 
PSF in terms of three dimensional resolution, and by measuring the offset between the US and 
PA imaging planes, in water and in a scattering medium. We conclude with a discussion of the 
implications of our findings for catheter design. 
2. 2 Methods  
2.2.1 Catheter design parameters 
For IVPA imaging, the illuminated area should lie within the field of view of the ultrasound 
transducer, as illustrated in Fig. 1(a). In a longitudinally offset dual beam design, the optical 
port of the catheter is positioned proximal from the ultrasound transducer. The beam emanates 
from the catheter under an angle to illuminate the tissue in front of the transducer. In optimizing 
the design of the catheter, we studied the effect of the probe geometry on the three-dimensional 
structure of the PSF. We work with multimode silica optical fiber of NA=0.22, with an angle-
polished tip that is covered by a glued-on quartz cap to preserve an air-glass interface (Pioneer 
Optics, 400 µm core diameter, low OH). If we require that the marginal ray emanating from 
the fiber still satisfies the total reflection criterion, the maximum angle under which the fiber 
can be polished is 34°, deflecting the beam by total reflection at a 68° angle. A smaller angle 
will lead to a more forward-directed beam, which is undesirable. We therefore choose to keep 
the polishing angle of the fiber tip fixed at this value. 
To avoid the acoustic specular reflection of the catheter sheath (not shown in the illustrations) 
which will be needed for in vivo imaging, the ultrasound transducer can be tilted relative to the 
catheter central axis. This angle affects the overlap between the optical and ultrasound beams 
and hence the PSF shape. We fixed the longitudinal offset between the fiber tip and the center 
of the transducer at the minimum achievable value of 1.1 mm. 
We simulated the beam overlap at different tilt angles θ of the transducer (positive clockwise 
with respect to the probe axis; cf. Fig. 2.1(a)) by computing the PA signal response as the 
product of the US beam profile and the optical fluence distribution. The US beam profile of 
the transducer (0.4 x 0.4 mm, lead magnesium niobate-lead titanate [PMN-PT]; center 
frequency 45 MHz; –6 dB fractional bandwidth of 45%; custom built by the Dept. of 
Biomedical Engineering, University of Southern California [25]) was measured by a needle 
hydrophone (75 µm tip, calibrated from 2 to 60 MHz, Precision Acoustics, Dorchester, UK) in 
clear water at room temperature, and the optical beam profile was simulated assuming a 
Gaussian beam profile, NA=0.22 for the fiber, and ignoring lensing effects of the quartz cap 
on the fiber in the plane of the catheter. Both beams profiles are normalized to their respective 
maxima. The overlap range is defined as the imaging depth where the overlap intensity is more 
than -25dB (0 dB indicates the complete overlap of the dual beam maxima). 
The overlap range and the maximal overlap intensity versus different transducer position angles 
are plotted in Fig. 2.1(b). The overlap intensity is higher, but with shorter range, at negative 
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transducer angle, showing a trade-off between sensitivity and viewing depth. The geometry of 
the intersecting beams for θ = 6°, combined with the contour graph of the PA response, is 
shown in Fig. 2.1(c). It clearly shows the beam overlap of the catheter,, extending from around 
1.3 mm to 6.3 mm from the transducer, with the distance from about 2 to 4mm as the optimal 
imaging range. It also shows, importantly, that the PA response as indicated by the contour 
plot does not coincide with the US response, but is shifted proximally for small depths. This 
means that there is a variable offset between the US and PA images.
 
Figure 2.1(a) Schematic of the integrated IVUS/IVPA catheter depicts the light path (red), the US beam path (green) and 
generated ultrasound signal (black arcs). We vary the transducer tilt angle θ. (b) The dual beam overlap range and 
maximum overlap intensity versus transducer position angles. The angle is defined with respect to the probe axis and 
positive clock-wisely (c) US and optical beam profile of the catheter overlaid with contour graph of the overlap intensity 
in dB. 0 dB corresponds to the maximum response when the beams are fully overlapping. 
We built an integrated US/PA probe with an outer diameter of 1 mm. We choose a transducer 
tilt angle of θ = 6°, which is a reasonable compromise between overlap range and intensity. A 
gold layer was sputter-deposited on the front of the transducer to serve as an electrode and 
optical isolation. An outer matching layer of parylene with 14 µm thickness was applied by 
vapor deposition (Philips Innovation Services, Eindhoven, the Netherlands) on top of the gold 
layer. The fiber tip and the transducer were mounted in a custom machined stainless steel 
assembly. The photographs of the catheters in Fig. 2.2 show the transducer configuration (prior 
to application of the metal film and coating).  
 
Figure 2. 2 Photographs of the catheter (before application of the gold optical isolation layer) (a) Front view, with light exiting 
the optical fiber tip. (b) The catheter tip on the edge of a 10 eurocent coin. The outer diameter of the tip is 1.0 mm 
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2.2.2   Combined IVPA/IVUS imaging system 
A diagram of the combined IVPA/IVUS imaging system is illustrated in Fig. 2.3 [11]. The 
excitation source for photoacoustic imaging was provided by a tunable laser (Vibrant B/355-
II, OPOTEK, Santa Clara, CA, USA). It provides high-energy laser pulses at a repetition rate 
of 10 Hz and a pulse width of 5 ns within 420 to 2200 nm spectral range. The output energy 
varies with wavelength. A tapered multimode optical fiber (Oxford Electronics, Four Marks, 
UK; input diameter 1mm; output diameter 360 µm) coupled the laser light to the catheter; 
typical coupling losses from laser to catheter tip amount to ~80%. For pulse-echo imaging, 
Gaussian-modulated cosine pulses with a peak-to-peak amplitude of 16 V were generated by 
an arbitrary waveform generator (WW2571A, Tabor Electronics, Tel Hanan, Israel) and 
transmitted to the catheter through a custom-built expander and limiter. The received US and 
PA signals were amplified by a 43 dB amplifier (AU1263, MITEQ, Long Island, New York, 
USA), band pass filtered (13–60 MHz 5th order Butterworth, custom built) and digitized at a 
sampling frequency of 350 MHz by a 12-bit data acquisition card (Acqiris DP310, Agilent 
Technologies, Santa Clara, CA, USA). A pulse/delay generator (BNC model 575, Berkeley 
Nucleonics Corporation, San Rafael, CA, USA) provided timing and triggering signals upon 
receiving a master trigger from the Q-switch of the laser.  The catheter was translated and 
rotated by a motorized translation and rotary stage (MP 63-25-DC and DT 105, Steinmeyer 
GmbH & Co. KG, Albstadt, Germany), respectively.  
 
Figure 2.3. Diagram of the combined IVPA/IVUS imaging system; AWG: arbitrary waveform generator, DAQ: data 
acquisition, delay: pulse/delay generator; bpf: band pass filter. 
2.2.3 Experiments 
To gain insights into the imaging characteristics of the catheter, measurements on an isolated 
target at the wavelength of 760 nm (the energy of the laser is about 1 mJ per pulse out of the 
catheter) were performed. Although contrast for lipid in atherosclerotic plaque tissue is found 
at wavelengths beyond 1 µm, we chose to work at a wavelength with minimal water and lipid 
absorption to prevent a background PA signal from affecting the measurements. We 
characterized the spatial resolution, signal to noise ratio (SNR), and the PA imaging plane 
curvature. A single 30 µm diameter tungsten wire was used as an isolated target. In the 
measurement, the image plane was defined as the plane perpendicular to the catheter, 
containing the image lines. The tungsten wire was first positioned perpendicular to the catheter 
for measuring the resolution in the axial (along the image line) and longitudinal (parallel to the 
catheter axis, perpendicular to the imaging plane) directions, and then parallel to the catheter 
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for the lateral (perpendicular to the catheter in the imaging plane) resolution measurement. In 
both configurations, a 2D scan in the plane perpendicular to the tungsten wire was performed 
with the geometry illustrated in Fig. 2.4(a). In US mode, the lateral and longitudinal resolution 
can be assumed similar based on the symmetric US beam profile. 
The measurements were conducted in clear water and in 0.5 vol% intralipid (Intralipid ® 20%, 
Fresenius Kabi Nederland BV, ‘s Hertogenbosch, The Netherlands; diluted 1:40 v/v) solution 
at room temperature. Intralipid is used as the scattering medium, broadening the optical beam 
to simulate the effect of tissue. At 0.5 vol%, the absorption coefficient of intralipid is µa = 
0.0024 mm-1, and the reduced scattering coefficient is approximately µs’ = 0.5 mm-1 [26]. It is 
similar to the optical scattering coefficient in human coronary artery tissue, which is around 
0.6 mm-1 [27]. The PA imaging curve was determined as the distance from the transducer to 
the signal maximum at all probe positions in the configuration of the wire perpendicular to the 
catheter. The spatial resolution was determined from the -6 dB width of the wire signal 
envelope. The SNR was computed as the difference between the wire signal maximum and 
background noise level in dB. 
Next, we imaged a cylindrical vessel phantom and a human coronary artery to evaluate the 
imaging capability of the catheter. The vessel phantom is made of 10% poly-vinyl-alcohol 
(PVA) with 1% enamel paint as acoustic scatters (three freeze/thaw cycles of at least 2h) and 
has a 3 mm diameter lumen. Six metallic wires of 100 µm diameter located at 1.5 to 4 mm 
distance from the lumen were incorporated as targets. Each cross sectional image consists of 
360 imaging lines at 1° spacing. A human coronary artery (left anterior descending artery, male, 
80 years old) was collected at autopsy from the Department of Pathology of the Erasmus 
Medical Center (MC), after obtaining consent from the relatives and approval of the research 
protocol by the Medical Ethics Committee of the Erasmus MC (MEC-2007-081). The coronary 
artery was frozen within 2h at -80°, then thawed and measured 13 months later. After imaging, 
Oil Red O (ORO) staining was performed at the imaging cross section to identify lipids in the 
artery (lipids are stained red in ORO staining).  
All the stored raw data were digitally band pass filtered between 10 and 70 MHz, using a 100th 
order zero-phase forward and reverse finite impulse response (FIR) filter. All PA and US data 
were subsequently Tukey windowed and envelope filtered. The vessel phantom and human 
artery data were first scan-converted to Cartesian coordinates, and then logarithmically 
compressed for display. 
 
2.3 Result 
2.3.1 Spatial resolution and SNR 
Figure 2.4 shows the spatial resolutions and SNRs of the catheter on the PA/US measurement 
of a 30 µm diameter tungsten wire at different depths (black dots are in clear water and red 
dots are in 0.5 vol% intralipid solution). As expected, the US images are not affected by the 
introduction of intralipid. The highest US SNR is 60 dB at the depth of 1.5 mm. The US axial 
resolution is independent of depth at approximately 43 µm while the lateral resolution keeps 
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increasing with depth in the far field of the transducer. In PA images, the intralipid only affects 
the SNR. The highest PA SNR is 63dB at the depth of 2.2 mm in clear water. After introduction 
of 0.5 vol% intralipid, the PA SNR decreases at all depths, typically 10~20 dB at depths greater 
than 1.4 mm. The maximum PA SNR is 43 dB at the depth of 1.5 mm. The PA axial resolution 
is independent of depth at around 52 µm. The lateral resolution (in the image plane) increases 
from 125 to 400 µm at depths from 1 to 4 mm.  The PA longitudinal resolution increases from 
400 µm close to the probe to 2000 µm at depths up to 8 mm.  
 
 
Figure 2.4. The spatial resolutions and SNRs of the probe on the measurement of a 30 µm tungsten wire in clear water 
(black dots) and 0.5 vol% intralipid solution (red dots). (a) The geometry of the measurements. (b-d) The SNR and 
spatial resolutions of the US images. (e-h) The SNR and spatial resolutions of the PA images. 
 
To quantify the spatial resolution and SNR of the catheter, the spatial resolution and SNR at 
the natural focus of the transducer (2.1 mm for this transducer) in clear water were used. The 
results are listed in Table 2.1.  
Table 2.1. Resolutions and SNRs of PA and US measurements on the single tungsten wire in clear 
water at the natural focus of the transducer 
Imaging 
Modality 
Resolution (µm) 
SNR (dB) 
Axial Lateral Longitudinal 
PA 52 215 500 62 
US 43                       205 60 
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2.3.2 IVPA imaging plane curvature 
The mismatch between the US and PA PSF leads to a longitudinal shift of the signal received 
from the single wire target by both modalities, which is shown in Fig. 2.5(b, c). In the figure, 
there is an offset of approximately 0.5 mm between US and PA signals in clear water (cf. Fig. 
2.5(b)). Introduction of optical scattering leads to a broader optical beam and a more uniform 
light fluence distribution. The offset is resolved, albeit at a cost of SNR owing to the fluence 
reduction (cf. Fig. 2.5(c)). The PA imaging plane curve of the catheter in clear water (white 
dots) overlaid on the combined PA beam profile (from Fig. 2.3) is shown in Fig. 2.5(d).  
Similarly, the PA beam profile in 0.5 vol% intralipid can be computed by the product of the 
measured US profile and the simulated optical beam profile using Monte Carlo method.  Fig. 
2.5(e) shows the PA beam profile in 0.5 vol% intralipid overlaid with the PA imaging plane 
curve of the catheter (white dots). The measured PA imaging curve agrees well with the 
computed overlap of the optical and ultrasound beams in both clear and optical scattering 
medium. Figure 2.5(f) shows the offsets between PA and US imaging planes in clear water 
(black dots) and in 0.5 vol% intralipid (red dots). In clear water, the PA and US imaging planes 
intersect at the depth of 2.7 mm, as expected from the probe geometry (the face angle of the 
polished fiber and the distance between the fiber tip and the transducer). Up to a depth of about 
7 mm, the offset between PA and US imaging planes is within [-1 0.5] mm. After introduction 
of 0.5 vol% intralipid to the water, the offset is reduced to [-0.1 0.3] mm, practically vanishing 
beyond the intersection point.  
 
Figure 2.5. The PA imaging point spread function in the catheter plane. (a) The configuration of the measurements. 
(b) fused PA/US image of the single wire in water. (c) fused PA/US image of the single wire in 0.5 vol% intralipid 
solution (d) and (e) are PA imaging curve overlaid on the graph of the dual beam overlap in clear water (d) and in 0.5 
vol% intralipid (e). In both figures, the longitudinal distance 0 is the position with maximal intensity. (f) the offset 
between PA and US imaging plane in longitudinal direction in clear water (black dots) and 0.5 vol% intralipid solution 
(red dots). 
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2.3.3  Imaging capability 
            2.3.3.1 Vessel-mimicking phantom 
The images of the vessel phantom are presented in Fig. 2.6. All 6 wires are clearly visible. In 
the PA image, reverberation or ‘comet-tail’ artefacts [28] can be seen behind the wires close to 
the transducer. In the US image, the center ring is caused by the ‘ringing’ of the transducer 
during the transmission of ultrasound pulses. 
 
Figure 2.6. Images of the cylindrical vessel phantom. (a) Photograph of the phantom, taken from the top. (b) PA image; 
(c) US image; (d) Overlaid PA/US image of the vessel phantom. The dynamic range is 45 dB in the PA image and 50 
dB in the US image. 
 
      2.3.3.2 Human coronary artery  
Figure 2.7 shows the co-registered IVPA/IVUS ex vivo images of the artery at the wavelength 
of 1205 nm (high lipid absorption). In the IVUS image (cf. Fig. 2.7(a)), the border of the artery 
is clearly visible from 5:00 to 2:00 o’clock position. In the IVPA image (cf. Fig. 2.7(b)), there 
are bright signals from 12:00 to 9:00 o’clock position inside the artery wall, indicating the 
presence of a lipid-rich plaque. There are also bright signals mapping the lipids in peri-
adventitial tissue observed from 6:00 to 12:00 o’clock position outside the artery wall. All the 
locations of the lipid regions were confirmed by the ORO histological data (lipids are red).  
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Figure 2.7. Cross-sectional IVPA and IVUS images of the human artery. (a) US image of the human artery, dynamic range is 
45 dB; (b) PA image of the human artery, dynamic range is 25 dB; (c) The fused PA and US image of the human artery; (d) 
Histology: Oil Red O stain of the IVPA and IVUS imaging cross section (lipids are shown in red). 
 
2.4 Discussion and summary 
We presented a design study of an integrated photoacoustic and ultrasound catheter for 
combined IVPA/IVUS imaging. We characterized and quantified its imaging characteristics 
by a measurement on isolated targets. PA and US axial resolutions are 52 and 43 µm 
respectively, while the lateral resolutions are 215 and 205 µm at the natural focus distance, 
respectively. The SNR at this location was more than 60 dB for US in clear water and in 0.5% 
intralipid, as well as for PA in clear water; in 0.5% intralipid the maximum PA SNR dropped 
to 43 dB. This decrease is the effect of lower fluence in the scattering medium compared to 
clear water. The imaging performance of the probe was demonstrated by measurements on a 
cylindrical vessel phantom containing metal wires and an atherosclerotic human coronary 
artery. A usable imaging range of 8 mm was demonstrated, which is almost double that of the 
previous high-resolution devices [17].  
The IVPA imaging plane is curved due to the non-collinear beams. The spatial PA response 
can be accurately modeled by a simple product of the overlapping beams in clear and optical 
scattering medium, which makes it a useful design tool for PA probes. The simulated fluence 
distribution in a scattering medium depends on the input optical properties, which not be 
exactly known. The PA and US imaging planes are shifted by [−1 0.5] mm up to 7 mm from 
the transducer. The design variables that can be used to reduce this offset are minimization of 
the distance between the fiber tip and transducer, and use of a large-NA fiber (which leads to 
increased bending losses in a flexible rotating probe). Optical scattering broadens the optical 
beam and flattens the fluence distribution, largely restoring the alignment between the PA and 
US imaging planes. For targets close to the transducer, the offset may not vanish entirely, as 
the light needs a certain propagation distance to diffuse sufficiently. 
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We attempted to simulate tissue optics by adding a scattering agent to the water bath in the 
experiments. It is as yet unclear if flushing of the blood, as is done in OCT [29] is preferable 
for in vivo IVPA [7, 14]. The details of the PSF shape in actual use will depend on the presence 
and optical density of blood [30] as well as the tissue optical properties of the vessel wall. In a 
vessel filled with clear flush media, 2-4 mm is an ideal imaging range for a catheter that is 
centered in the vessel. If the catheter is eccentric, which happens often, the far wall is still 
visible through the clear flush media. The near wall provides optical scattering, which brings 
the beam overlap point closer to the catheter, in the adjacent tissue. 
It is interesting to consider the effect of the non-collinear beams on other probe geometries. 
The parallel arrangement of fiber and transducer presented in [17] should still give rise to a 
curved point spread function in the imaging plane, although the close separation between the 
optical and ultrasonic beams in that device will minimize PSF curvature. Instead, transducer 
sidelobes were observed in the PA signal for close-range targets. In that study, optical 
scattering was not investigated, nor was there a comparison with a simulated beam profile. 
We measured a large difference in the PA resolutions in the longitudinal and lateral directions. 
The lateral resolution remained comparable to the ultrasound resolution over the entire imaging 
range, apparently limited by ultrasound beam width within the much broader illumination beam. 
The longitudinal resolution, however, is limited by the non-collinear catheter design, increasing 
to nearly 2 mm at a depth of 7 mm. In the longitudinally offset catheter design discussed in this 
study, it would mean that the resolution along the pullback direction would be compromised, 
but resolution in the cross-sectional images is preserved. The difference can likely be attributed 
to an asymmetry in the optical beam characteristics, possibly caused by the detailed structure 
of the optical tip and lensing by one of the curved surfaces. However, we could not characterize 
the fiber tip with sufficient accuracy to simulate the effect on the beam. 
The USC ultrasound transducer used in this study has excellent sensitivity, resulting in superior 
SNR, compared to many earlier designs, and the good axial and lateral resolutions benefit the 
cross-sectional images. Besides, its small size allows further reduction of the catheter diameter. 
Whether the frequency of 45 MHz is optimal for imaging of coronary atherosclerosis is the 
subject of ongoing experiments. The offset between optical and ultrasonic beams can be 
minimized by placing the transducer as close to the optical fiber tip as possible and using 
thinner fibers, which will also enable a further decrease in size to 0.7 mm tip diameter. 
We observe a PA transmit artifact, which can be seen as the near-field signal in Fig. 2.5 (a) and 
(b). A photoacoustic signal can be generated directly in the transducer or in the transducer 
housing which is in mechanical contact with the transducer, if the light is absorbed by the probe 
itself. This signal appears immediately after the emission of the laser pulse, as there is no time 
of flight. In the presence of optical scattering, the light fluence close to the probe is higher and 
the signal is proportionally larger. An effect of the probe geometry is the reduced transducer 
light exposure with larger positive tilt angles (transducer is tilted away from optical fiber). 
Anecdotally, we compared the strength of this artefact generated by the probe discussed in this 
paper with a previous prototype using a tip made out of polyether ether ketone (PEEK) [19]. 
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Figure 2.8 shows that the stainless steel tip probe exhibits an artefact that is about 10 dB 
stronger and extends for > 2 µs after the laser pulse. This difference may be explained by 
assuming that the white PEEK tip of the 30 MHz catheter is non-absorbing, and any vibrations 
quickly decay by dissipation in the mounting epoxy. Covering the transducer front surface with 
a metal film is essential to minimize this unwanted signal. The steel tip, however, holds the 
optical fiber tip itself and cannot be effectively shielded from the light. Vibrations excited in 
this metal structure also persist for longer, leading to a more prominent artifact. 
 
Figure 2. 8. PA images showing the transmit artefact. (a) PA image with the steel tip 45 MHz catheter and (b) PA image 
with the white PEEK tip 30 MHz catheter. The dynamic range is 60 dB in both images. 
In summary, we evaluated the design of an intravascular ultrasound/photoacoustic imaging 
probe. We demonstrated the various geometrical considerations affecting the PA PSF. 
Experiments showed how optical scattering can at least partially mitigate the complexity of the 
spatial response introduced by the choices made in the design of the catheter tip. There is a 
trade-off between viewing depth and sensitivity resulting from the overlap between the optical 
and ultrasound beams. Finally, we discussed how the tip design can minimize light absorption 
in the catheter tip, which creates a prominent artifact that is difficult to avoid with a small probe 
used in reflection geometry. 
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Abstract  
 
The lipid content in plaques is an important marker for identifying atherosclerotic lesions and 
disease states. Intravascular photoacoustic (IVPA) imaging can be used to visualize lipids in 
the artery. In this study, we further investigated lipid detection in the 1.7-µm spectral range. 
By exploiting the relative difference between the IVPA signal strengths at 1718 and 1734 nm, 
we could successfully detect and differentiate between the plaque lipids and peri-adventitial fat 
in human coronary arteries ex vivo. Our study demonstrates that IVPA imaging can positively 
identify atherosclerotic plaques using only two wavelengths, which could enable rapid data 
acquisition in vivo.  
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3.1 Introduction 
The rupture of vulnerable atherosclerotic plaques is a major cause of acute cardiovascular 
events and sudden cardiac death [1]. One of the most common types of vulnerable 
atherosclerotic plaques is the thin-cap fibroatheroma (TCFA). It is characterized by the thin 
fibrous cap with macrophage infiltration, covering a lipid rich necrotic core [2, 3]. Lipid in 
particular is a crucial component and is used as a biomarker for detecting atherosclerotic 
plaques [4-7]. A technology that directly, specifically and reliably images plaque lipid content 
can be used for guiding diagnosis and interventions without observer-dependent and time-
consuming interpretation. Such a technology is presently not available for use in patients. 
Intravascular photoacoustic (IVPA) imaging is a new catheter-based hybrid optical-acoustic 
modality for imaging atherosclerotic plaques which could meet that clinical need [8-10]. It can 
detect lipids on the basis of optical absorption contrast. However, choosing the wavelengths 
most suitable for lipid detection by IVPA imaging is critical. We know that lipids are highly 
effective absorbers at wavelengths near 1.7 µm and 1.2 µm due to the first and second overtone 
of the vibration of C-H bonds within lipid molecules [4, 11, 12]. The capability of IVPA 
imaging to detect lipids at both spectral ranges in the coronary arteries has been demonstrated 
ex vivo [13, 14] and in vivo [15]. In a typical atherosclerotic artery, lipids can be found in the 
plaque inside the artery wall, while peri-adventitial fat is present around the artery wall also in 
normal coronary arteries in the aging heart. While lipids in the plaque mainly consist of 
cholesterol and certain cholesteryl esters [16, 17], the lipids in the peri-adventitial fat are stored 
as a mixture of fatty acids [18, 19]. This difference makes it possible to differentiate between 
these two lipids. Peri-adventitial fat is distributed around arteries throughout the body [20]. A 
modality that visualizes only lipids in plaques, excluding peri-adventitial fat, can highlight the 
presence and location of lipid-rich plaques (LRP) in vessel cross-sections and longitudinal 
sections through a pullback data set, without having to rely on IVUS image analysis. Unique 
LRP detection can be a valuable tool for guidance of percutaneous coronary interventions 
(PCI).  
A number of recent studies advocated the use of a single wavelength for lipid imaging [11, 
15].We observed that other plaque components may also generate a signal at that chosen 
wavelength, as is illustrated in Fig. 3.1. In the figure, only the PA signal from 1 o’clock to 3 
o’clock (in the light blue box) was generated from plaque lipids. The signals from 3 o’clock to 
7 o’clock inside the vessel (in the green box) were generated from calcium (black in the ORO 
stained section), while the strong signal surrounding the vessel from 9 o’clock to 3 o’clock was 
generated from the peri-adventitial adipose tissue. The observation shows that reliable lipid 
detection requires multiple wavelengths. We have previously investigated the possibility of 
specific plaque lipid imaging using IVPA [13, 21], and demonstrated that lipids in plaques can 
be differentiated from those in peri-adventitial fat using the correlation between the observed 
PA spectra data and the reference PA spectra data. This analysis requires at least 3 wavelengths 
in the 1.2 µm range. However, using multiple wavelengths impacts the complexity, cost, and 
speed of the imaging system, and hence the viability of IVPA as a clinical imaging technique.  
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Figure 3.1. Ex vivo IVPA/IVUS image of a human coronary artery. (a) Histology: Oil Red O staining of the imaging cross 
session. (b) 3 x magnification of a part of vessel wall (area outlined in green in (a)). (c) 10 x magnification of a part of vessel 
wall (area outlined in light blue in (a)). (d) 1710 nm combined IVPA/IVUS images of the same cross session shown in (a). 
The image also shows a strong signal from the adipose tissue surrounding the vessel from 9 o’clock to 3 o’clock. The dynamic 
range is 55 dB in the US image and 22 dB in the PA image. 
  
The larger absorption coefficient of lipids in the 1.7 µm wavelength band allows us to work at 
lower laser pulse energies (compared to 1.2 µm) to achieve a reliable PA signal, which is 
attractive for safety, cost and usability of the technology in a real-world clinical setting. 
 In this work, based on the statistical analysis of the spectra of different lipid samples, we 
present a method to automatically detect and differentiate plaque lipids using only two 
wavelengths in the 1.7 µm range, enabling a fast image acquisition for in vivo application. The 
performance of this presented method was tested on a vessel phantom and on ex vivo human 
coronary arteries. 
3.2 Method and material 
3.2.1 Imaging system 
We used a combined IVPA/IVUS imaging system to obtain co-registered IVPA/IVUS images 
as described before  [13, 22]. Briefly, the laser pulses for IVPA imaging were provided by a 
tuneable laser (Vibrant B/355-II, OPOTEK, Santa Clara, CA, USA; Pulse energy 650 µJ/pulse 
at 1700 nm, pulse duration 5 ns, repetition rate 10 Hz). The laser light was coupled into the 
custom built catheter by a tapered multimode optical fiber (Oxford Electronics, Four Marks, 
UK; input diameter 1 mm; output diameter 360 µm). Our catheter mainly comprised a 400 µm 
diameter core optical fiber with an angle-polished tip (Pioneer Optics, Hartford, Connecticut; 
tip angle = 34°, NA = 0.22) and a 0.4 x 0.4 mm lead magnesium niobate-lead titanate (PMN-
PT) ultrasound transducer (Dept. of Biomedical Engineering, University of Southern 
California; 45 MHz central frequency, 45% relative bandwidth) [22, 23]. The catheter was 
positioned by a motorized stage (MP 63-25-DC and DT 105, Steinmeyer GmbH & Co. KG, 
Albstadt, Germany). A pulse/delay generator (BNC model 575, Berkeley Nucleonics 
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Corporation, San Rafael, CA, USA), triggered by the Q-switch of the laser, provided 
synchronisation signals to the data acquisition card and arbitrary waveform generator 
(WW2571A, Tabor Electronics, Tel Hanan, Israel) for pulse echo imaging.  
3.2.2 Lipid spectroscopy 
To investigate the possibility of lipid detection and differentiation in the 1.7 µm range, the 
spectra of the lipids in plaque and peri-adventitial fat were measured. The spectra of lipids in 
plaques were measured with pure cholesterol, cholesterol oleate and cholesterol linoleate 
samples (Sigma Aldrich Co., C8667, C9253 and C0289, respectively), which are dominant 
lipids in human atherosclerotic plaques [16, 24]. The spectra of the lipids in peri-adventitial fat 
were measured directly using the human peri-vascular adipose tissue. We filled one lipid 
sample at a time in a custom-built TPX holder (TPX® Polymethylpentene) and positioned the 
holder in front of the ultrasound transducer to optimize the signal-to-noise ratio (SNR) of the 
PA signal.  
Spectroscopic photoacoustic imaging (sPA) was performed in the spectral range from 1620 to 
1780 nm with a step of 2 nm in clear water at room temperature. The laser energy for sPA 
imaging was about 0.35 mJ/pulse at the catheter tip. To improve the PA SNR, 32 A-lines were 
averaged at every wavelength.  We acquired at least 500 PA spectral data sets per lipid sample. 
These spectra were used as a reference. We performed statistical analysis to investigate the 
spectral contrast between different lipid samples. Since the sPA data were acquired within a 
narrow spectral range (1620 to 1780 nm), the variations of the average laser pulse energy and 
the tissue scattering properties were negligible. Any differences in the PA signal were assumed 
to only arise due to the optical absorption contrast in this spectral range. All the lipid spectra 
were filtered using a Savitzky-Golay FIR smoothing filter and normalized to their respective 
maxima for display. 
Typical spectra of the different lipid samples are shown in fig. 3.2(a). In the figure, the spectra 
of different lipid samples are relatively similar. The dominant differences of the spectra 
between lipids in plaque and in peri-adventitial tissue are shifts in the locations of the peaks, 
and these differences make it possible to differentiate between the lipids in plaques and in peri-
adventitial tissue.  
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Figure 3.2. The spectra of different tissue types in 1.7µm spectral range. (a) The normalized PA spectra of different lipid 
samples. (b) The spectra of elastin, collagen, water,  and calcium  obtained from  refs. [25-27, 29]. All spectra are normalized 
to their respective maxima.  
 
3.2.3 Criteria for lipid detection and differentiation 
Choosing optimal PA excitation wavelengths for specific plaque lipid detection is critical. In 
order to minimize time and power overhead, we aim to select two wavelengths only. The ideal 
pair of wavelengths is closely spaced (to avoid any fluence changes due to water absorption or 
tissue optics) and provides sufficient PA contrast for lipid detection and differentiation. In the 
1.7 µm spectral range, lipids produce a usable PA signal between 1680 and 1750 nm, where 
lipid absorption exceeds that of water [25, 26]. 
To differentiate the plaque lipids and peri-adventitial fat, we plotted the difference between the 
cholesterol (representative of plaque lipid) and peri-adventitial fat normalized spectra in Fig. 
3.3. The figure shows that there are four wavelengths exhibiting a large contrast, which are 
marked with red dots. Plaque lipid has a larger PA signal at 1686 nm and 1734 nm, while the 
peri-adventitial fat response dominates at 1718 nm and 1750 nm. A pair of wavelengths is 
selected based on the contrast of the two-wavelength relative difference in PA signal of the 
tissue types that may be expected to occur in the coronary artery wall: lipids, water, calcium 
and the connective tissues (elastin and collagen). Normalized PA spectra for these non-lipid 
tissues are shown in Fig. 3.2(b) [26-29]. The relative PA difference ΔPA is defined as follows: 
1 2
1
ΔPA
PA PA
PA
 


  
where 
1
PA  and  2PA are the PA amplitudes at the two wavelengths. Note that for noise 
immunity, lipids should generate PA signals with good SNR at the selected wavelengths. Of 
these four wavelengths, 1718 nm is close to the peak response of all lipids, and hence always 
generates a strong signal. We choose this wavelength as λ1 to avoid the denominator in ΔPA 
becoming small and to decrease the sensitivity to noise. Adequate contrast and acceptable noise 
sensitivity can be achieved with λ1 = 1718 nm and λ2 = 1734 nm, which is the nearest usable 
wavelength. 
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Figure 3.3. Difference in PA normalized spectra between cholesterol and peri-adventitial fat. Four wavelengths produce a 
large enough difference to be useful for distinguishing the two. 
We computed ΔPA at 1718 and 1734 nm, for all spectra acquired on the different lipid samples 
and performed statistical analysis on the results, shown in Fig. 3.4. This representation shows 
how ΔPA  can be used for tissue characterization. Water, calcium and connective tissues 
have ΔPA ≤ 0, while for lipids this quantity is always positive. Fatty acids have a larger 
relative difference than plaque lipids. We can discriminate between plaque lipids, peri-
adventitial fat, and other tissue components by setting two thresholds: ΔPA > 0.1 for all lipids 
(red dashed line in Fig. 3.4) and 0.1 < ΔPA < 0.35 for plaque lipids. The former threshold 
accounts for an unknown experimental variability in the PA spectra of collagen, elastin, and 
calcium, which were based on literature data, as well as a potential underestimation of the 
variance in the ΔPA of plaque lipid related to composition differences. There is a small overlap 
of the relative differences between the plaque lipids and peri-adventitial fat. The upper 
threshold was defined as the minimum of the measured relative differences of peri-adventitial 
fat in our data set. In this way, most of the atherosclerotic plaques are detected while the other 
normal components of the artery wall (such as peri-adventitial fat) are excluded, minimizing 
the false-positive rate.  
 
Figure 3.4. The relative difference between different tissue types at the wavelength of 1718 and 1734 nm plotted as 
average 
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3.2.4 Ex vivo experiments 
3.2.4.1 Vessel mimicking phantom experiment 
To test the presented method, we performed IVPA/IVUS imaging on a poly-vinyl-alcohol 
(PVA) vessel mimicking phantom (10% wt. PVA crystals in demineralized water, 3 
freeze/thaw cycles of at least 2h). The phantom has a 3 mm diameter lumen with four 
cylindrical cavities 0.5 mm apart from the lumen. All the cylindrical cavities are 1.5 mm round 
by 5 mm deep. One cavity was filled with human peri-adventitial fat from a coronary artery 
specimen. The other three cavities were filled with pure cholesterol, cholesterol oleate and 
cholesterol linoleate samples (Sigma Aldrich Co., C8667, C9253 and C0289), respectively. A 
photo of the filled PVA vessel phantom is shown in Fig. 3.5(a).   
The phantom was placed in clear water at room temperature. The catheter was positioned inside 
the lumen of the phantom to image all the lipids filled in the cavities. By rotating the catheter 
360° in 1° steps, the full cross-sectional IVPA/US images of the phantom were acquired. At 
every rotation angle, the laser was tuned between 1718 and 1734 nm to ensure the co-
registration of the IVPA data at both wavelengths. US images were 8 times averaged; no 
averaging was applied for PA images. 
  3.2.4.2 Human coronary artery measurement 
We collected human coronary arteries at autopsy from the Department of Pathology of Erasmus 
Medical Center (MC), after obtaining consent from the relatives. The research protocol was 
sanctioned by the Medical Ethics Committee of Erasmus MC (MEC-2007-081). The coronary 
arteries were frozen within 2h at -80°, then thawed and measured within 2 months. In the 
measurement, we fixed the artery on top of a custom built TPX tissue holder with an array of 
200 µm thick metal wires glued every 1.5 mm at the bottom. The metal wires were clearly 
visible in the IVPA/IVUS images and used as the marker to register the imaging position. The 
tissue holder was placed inside a water tank filled with saline solution at room temperature. 
Spatially co-registered two-wavelength (1718 and 1734 nm) IVPA and IVUS images were 
obtained by rotating the catheter inside the lumen of the artery in 1° steps and repeating PA 
and US acquisitions at every step. IVUS images were 10 times averaged; no averaging was 
applied for PA images. 
After the IVPA/IVUS imaging, we cut the artery at the two wires adjacent to the imaging plane, 
embedded in optimal cutting temperature (OCT) compound (Tissue-Tek®, Sakura Finetek 
Europe B.V.), and then were frozen on dry ice, and stored at -80°C until further processing. 
For histopathology, we cut into the tissue block until the imaged location was reached. A series 
of 10 µm thick sections were thaw mounted on slides and stained with Oil Red O (ORO) to 
identify lipids in the artery (lipids are stained red in ORO staining). 
3. 2.4.3 Data processing 
All the stored US and PA data were digitally band pass filtered (10 to 70 MHz, 100th order 
zero-phase forward and reverse finite impulse response (FIR) filter), Tukey windowed, 
envelope filtered, artefacts removed and converted for display as discussed in our previous 
work [13].  Specifically, absorption of laser pulses in the catheter tip generates an artefact in 
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the PA data that is proportional to the laser pulse energy. We used the magnitude of this signal 
to correct for variations in the laser energy between individual pulses and between the different 
wavelengths. The artefact was removed from the data by an adaptive filter that detects and 
suppresses highly correlated features across A-lines, spanning angles of more than 20 degrees. 
A binary denoising mask was defined to include all pixels where PA amplitude at 1718 nm is 
higher than the background noise threshold, and reject data elsewhere. The background noise 
threshold is calculated as the maximum envelope signal in a region of the image beyond the 
imaged object. This denoising mask was then applied to the pixel-to-pixel calculated relative 
difference between the PA signals at 1718 and 1734 nm as described in section 2.2. 
Subsequently, we obtained the lipid differentiation map by implementing the first cutoff 
threshold of 0.1 to detect all the lipids and the second cutoff threshold of 0.35 to identify only 
the lipid in plaques. The lipid differentiation map was then scan-converted to Cartesian 
coordinates, color coded (red for lipids in peri-adventitial tissue and yellow for lipids in 
plaques) and overlaid on the co-registered US images for display. 
To evaluate the presented method, we calculated the classification accuracy for plaque lipid 
detection. True positives are plaque lipid pixels inside the external elastic lamina (EEL), which 
separates the media and adventitia layer of the artery wall; true negatives are adipose-type 
lipids pixels outside the EEL. Plaque lipid pixels outside the EEL are classified as false 
positives; as explained above, minimization of the number of false positives is important for 
clinical application. False negatives are not detected, as plaques often comprise a fraction of 
non-cholesterol lipids. We report performance as the number of plaque lipids inside and outside 
the EEL. The former is expected to be greater than zero but less than 100% because of the 
presence of fatty-acid-like lipid species; the latter should be as small as possible as no 
cholesterol-like molecules occur in adipose lipids.  
3.3 Results 
3.3.1 Lipid imaging in a vessel mimicking phantom  
Fig. 3.5 (b) shows the lipid detection and differentiation results of the PVA vessel mimicking 
phantom. In the figure, all lipid samples inside the four holes were clearly visible and the lipid 
differentiation results agreed with the phantom arrangement very well. The attenuation by the 
lipid samples (and water, to a degree) in the 1.7 µm spectral range limits the PA imaging depth 
to about 2.5 mm. We calculated the differentiation results and got 97.3% true positive and no 
false positive lipid differentiation in the PVA phantom.   
 
Figure 3.5. Lipid detection and differentiation result of the PVA vessel mimicking phantom. (a) The photo of the PVA vessel 
phantom with filled different lipid samples. (b) Lipid differentiation map fused with US image of the PVA vessel phantom. 
The lipids in plaques are in yellow and lipids in peri-adventitial tissue are in red. The dynamic range of the US image is 40 
dB. 
Chapter 3. Specific imaging of atherosclerotic plaque lipids with two-wavelength intravascular photoacoustics 
40 
3.3.2 Lipid imaging in a human coronary artery specimen 
Lipid content of a human atherosclerotic plaque was evaluated by IVPA in a left anterior 
descending artery (male donor, 80 years old). Histology shows the presence of a large eccentric 
plaque with abundant lipids both superficially and deeply located in the plaque (Fig. 3.6(a)). In 
Fig. 3.6(b), the EEL of the artery, separating the media and adventitia, is clearly visible in the 
IVUS image, and we marked the EEL by a light blue contour. The IVPA data confirm the lipid 
deposition that was identified in the histology, located from 12 o’clock to 9 o’clock inside the 
artery wall containing lots of extracellular lipid droplets. However, the lipids located from 9 
o’clock to 12 o’clock inside the artery wall remain undetected. These are mostly intracellular 
lipids, to which IVPA appears to be less sensitive [13]. The IVPA signal strength also varies 
the distance from the catheter depending on the probe geometry [22]. Inside this lipid-rich 
plaque, 76% of the lipids are identified as cholesterol-derived plaque lipids (in yellow). The 
lipid signal observed from 7 o’clock to 12 o’clock outside the artery wall comes from adipose 
tissue, and 84% of this is indeed identified as peri-adventitial adipose tissue (in red).  
 
Figure 3.6. Ex vivo lipid differentiation result of an atherosclerotic human coronary artery (LAD, male, 80 years old). (a) 
Histology: Oil Red O staining of the IVPA/IVUS imaging cross section (lipids are in red). (b) Lipid differentiation map 
overlaid on the co-registered US image of the coronary artery. The lipids in plaques are in yellow and lipids in peri-adventitial 
tissue are in red. The dynamic range of the US image is 45 dB.   
Ex vivo lipid differentiation in another human coronary artery is shown in Fig. 3.7. The 
histology of the artery (Fig. 3.7(a)) reveals absence of atherosclerosis in this cross section. All 
lipids in the ORO stain are located outside the artery wall. In the lipid differentiation map, all 
the detected lipids are shown outside the EEL (indicated by the light blue contour). We 
calculated that 95.5% of the detected lipids are identified as peri-adventitial adipose tissue.  
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Figure 3.7. Ex vivo lipid identification result of a human coronary artery (LAD, male, 54 years old). (a) Histology: Oil Red O 
staining of the IVPA/IVUS imaging cross section (lipids are in red). (b) Lipid differentiation map overlaid on the co-registered 
US image of the coronary artery. The lipids in plaques are in yellow and lipids in peri-adventitial tissue are in red. The dynamic 
range of the US image is 45 dB. 
All ex-vivo lipid identification results are presented in Table 3.1. The table lists the true 
(plaque lipids detected inside the artery wall) and false (plaque lipids detected outside the 
artery wall) plaque lipids detection results. Phantom case in shown in Fig.3.5 and human 
artery case 1 and 2 are described above in fig.3.6 and fig.3.7. In artery case 3, we achieved 
68% true positive and 18% false positive plaque lipid detection. In artery case 4, a large LRP 
was detected, and no peri-adventitial adipose tissue was visible due to insufficient laser light 
penetrating at its depth. In this case, we attained 67% true positive plaque lipid detection. 
Artery case 5 presents another clean artery and we achieved 14% false positive plaque lipid 
detection.  
Table 3.1. Ex-vivo plaque lipid detection results 
(Phantom case in Fig.3.5; artery case 1 in Fig. 3.6; artery case 2 in Fig. 3.7) 
 Plaque lipids inside EEL (%) Plaque lipids outside EEL 
(%) 
Phantom 97.3 0 
Artery case 1 76 16 
Artery case 2 -- 4.5 
Artery case 3 68 18 
Artery case 4 67 -- 
Artery case 5 -- 14 
 
3.4 Discussion and conclusion  
Our results have demonstrated that it is possible to detect and differentiate between the lipid in 
plaques and in peri-adventitial adipose tissue using relative difference of the PA signal at only 
two wavelengths, namely 1718 and 1734 nm. Small differences in the absorption spectrum of 
the different lipids in and around the artery make it possible to specifically identify plaque 
lipids by IVPA. To the best of our knowledge, the method presented here uses the lowest 
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number of wavelengths for detecting and differentiating between lipids in plaques and in peri-
adventitial adipose tissue.  
In a series of human coronary arteries ex vivo, we identify about 70% of lipids in plaques, and 
15% in the peri-adventitia tissue as cholesterol-like lipids. The latter number represents actual 
false positives. The former score may be affected by the variability of plaque lipid composition: 
Plaques also contain non-sterol lipids (e.g. triglycerides and phosphatidylcholines). These 
molecules do not contain a multiply connected carbon backbone, but rather consist of largely 
saturated hydrocarbon chains, which are likely to have a fatty-acid-like absorption spectrum. 
In a clinical application targeting coronary artery disease, specificity is preferable over 
sensitivity: it is more important to be sure that a detected LRP is actually a significant plaque, 
than to detect every small lipid deposit which is likely clinically irrelevant. We chose the upper 
threshold, separating plaque lipids from fatty acid, to prevent false positives as much as 
possible. 
The optimal wavelength selection needs to be confirmed by a more extensive ex vivo 
spectroscopy study, deriving more robust cut-offs from the spectral data of human coronary 
artery plaques instead of pure lipid samples. Such a study requires spectroscopic IVPA imaging 
of full cross-sections, and at present our laser system is too slow to allow us to perform this 
measurement; faster IVPA systems are on the horizon [30-32]. For technical reasons, the OPO 
system we used in this study has a tuning accuracy in this wavelength range of a few nm, which 
means that the reported wavelengths are indeterminate within that band. The general principle 
of the method reported here remains valid, but the wavelength calibration is somewhat laser-
dependent. 
One limitation of our method is that the identification results are sensitive to noise, as it relies 
on the precise determination of the ratio between two relatively weak signals. At 1734 nm, 
lipids generated just moderate PA signals, making PA images at this wavelength vulnerable to 
noise. Further noise reduction and increased transducer sensitivity will improve the accuracy 
and reliability of the lipid identification. Another limitation is that the PA imaging depth at 1.7 
µm is lower than that at 1.2 µm [21]. Nevertheless, the imaging depth we achieved in our ex 
vivo measurements of human coronary arteries at 1.7 µm was about 3 mm, which is sufficient 
to image human coronary arteries [21, 33]. The large absorption coefficient of superficial lipid 
did suppress the contrast of the deeper layer in the plaque shown in Fig. 6. As mentioned before, 
better detection sensitivity may help, although the strong superficial absorption at 1718 nm 
may actually “color” the light, causing a violation of the assumption that light at both 
wavelengths is equally attenuated, reducing ΔPA to below the threshold set for lipids, leading 
to underestimation of the plaque volume. This is a fundamental limitation in PA imaging that 
also affects oxygen saturation measurements in other applications [34, 35]. Deriving a fluence 
correction and smoothing the lipid differentiation map may help to mediate this light coloring 
effect.  
Our method will enable a rapid data acquisition, which is essential for clinical application of 
IVPA. In current clinical practice, LRP may be detected with high specificity by near-infrared 
reflection spectroscopy (NIRS) [6, 7, 36, 37]. A limitation of that technology in its commercial 
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form is its inability to determine the depth of lipid deposits in the vessel wall. IVPA amends 
that shortcoming by not just detecting, but imaging lipids. NIRS has positively demonstrated 
the clinical value of an overall assessment of the presence of LRP in the whole artery, which 
is done in a display that summarizes the entire pullback, obviating the necessity to inspect the 
data set frame by frame. Earlier implementations of lipid detection by IVPA [5, 11, 15, 38] 
were unable to discriminate between plaque and adipose tissue. Peri-adventitial fat is detected 
in almost all IVPA images, and specific plaque lipid imaging is needed to present a clinician 
with a rapid assessment of the presence of LRP and the cap thickness overlaying the lipid core, 
without tedious examination of every individual cross sectional image in the pullback or error-
prone automated IVUS image processing. 
In conclusion, we have presented here a technique to specifically image lipids in atherosclerotic 
plaques. It relies on subtle spectroscopic contrast between different lipid types in and around 
the artery, which we probe by two-wavelength IVPA. Two thresholds applied to this 
differential measurement make it possible to detect all lipid and separate plaque-specific lipids 
from the more common fatty-acid-like lipids. This technique enables rapid identification of 
thin-cap lipid-rich atherosclerotic plaque in coronary arteries. Its speed and moderate pulse 
energy open up an avenue of translating IVPA imaging to clinical application. 
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Abstract  
 
The identification of unstable atherosclerotic plaques in the coronary arteries is emerging as an 
important tool for guiding percutaneous coronary interventions, and may enable preventive 
treatment of such plaques in the future. Assessment of plaque stability requires imaging of both 
structure and composition. Spectroscopic photoacoustic (sPA) imaging can visualize 
atherosclerotic plaque composition on the basis of the optical absorption contrast. It is an 
established fact that the frequency content of the photoacoustic (PA) signal is correlated with 
the structural tissue properties. As PA signals can be weak, it is important to match the 
transducer bandwidth to the signal frequency content for in vivo imaging. In this ex vivo study 
on human coronary arteries, we combined sPA imaging and analysis of frequency content of 
the PA signals. Utilizing a broadband transducer (-3 dB one-way bandwidth of 10-35 MHz) 
and a 1 mm needle hydrophone (calibrated for 1-20 MHz), we covered a large frequency range 
from 1 MHz  to 35 MHz for receiving the PA signals. sPA imaging was performed at 
wavelengths ranging from 1125 to 1275 nm with a step of 2 nm, allowing discrimination 
between plaque lipids and adventitial tissue. Guided by sPA imaging, the frequency content of 
the PA signals from the plaque lipids was quantified. Our data shows that more than 80% of 
the PA energy of the coronary plaque lipids lies in the frequency band below 8 MHz. This 
frequency information can guide the choice of the transducer element used for PA catheter 
fabrication.  
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4 .1 Introduction 
A major cause of death worldwide is cardiovascular disease [1].  A substantial proportion of 
cardiac deaths are due to acute coronary syndromes.  The majority of these fatal acute coronary 
syndromes are caused by ruptures of vulnerable atherosclerotic plaques and thrombosis [2-4]. 
The identification of unstable atherosclerotic plaques in the coronary artery is emerging as an 
important tool for guiding percutaneous coronary interventions. The structure and composition 
of the plaque are significant determinants of its stability [5].  Imaging modalities has provided 
a greater understanding of factors involved in the atherosclerosis disease process and has 
improved therapeutic interventions [6]. Particularly, intravascular imaging approaches can 
characterize the burden, composition and functionality of atherosclerotic plaque, neointimal 
hyperplasia and allograft vasculopathy that develop within coronary arteries [6]. 
Currently available intravascular imaging modalities have limitations in that respect: 
Intravascular ultrasound (IVUS) imaging is unable to distinguish plaque constituents other than 
calcium [7, 8]. Intravascular optical coherence tomography (OCT) has better soft tissue 
contrast, but its penetration depth is limited to 1-3 mm, and it requires flushing blood from the 
lumen of the vessel [9], a limitation that also applies to angioscopy. The intravascular chemical 
sensing techniques near infrared spectroscopy, Raman spectroscopy and intravascular 
fluorescence imaging cannot provide depth-resolved information [10, 11]. 
Intravascular photoacoustic (IVPA) imaging, and particularly spectroscopic IVPA (sIVPA) 
imaging, aims to fill this gap by imaging plaque components in a vessel wall with reasonably 
large imaging depth [12-15]. This imaging technique, which applies pulsed light excitation, 
benefits from the optical absorption properties of tissue composition as contrast. Typically, 
photoacoustic (PA) imaging utilizes the signal envelope of the PA signal to reconstruct 
macroscopic optical absorbers in an image [16]. Theoretical solutions of the wave equation for 
simple geometries predict that the PA pressure amplitude is proportional to the radius of the 
absorber squared whereas the main frequency of the PA signal is inversely related to the size 
of the absorber [17]: larger sources will emit PA pressure waves with higher amplitude and 
lower frequencies compared to smaller ones. As PA signals can be weak for in vivo imaging 
applications, it is important to match the transducer bandwidth to the major frequency contents 
of the PA signal. The frequency content of PA signals has recently been investigated to estimate 
the microscopic properties of absorbers in phantoms [18, 19] and in more complex biological 
tissues [20-26]. The frequency content of plaque lipid PA signal has not been investigated to 
date, and may be distinct from e.g. the adipose tissues surrounding the vessel. While this peri-
adventitial fat has a homogeneous structure, there is variability in size, shape, and concentration 
of the lipid deposits, acting as PA sources, in plaque. This contrast in spatial structure affects 
the emitted acoustic frequencies. The small device size and stringent optical power limits of 
endoscopic applications mean that the signal-to-noise ratio (SNR) cannot be arbitrarily 
increased by larger sensor surface or excitation power, so optimization of the transducer 
sensitivity is a key step towards a reliable, safe, and usable IVPA technology. 
Generally, to obtain co-registered IVUS and IVPA images, transducers with central frequency 
of 30-85 MHz have been used, which guarantees decent IVUS images. However, in absence 
of any data on the typical frequencies generated by PA imaging in lipid-rich atherosclerosis, it 
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is unknown whether the frequency range of >30 MHz is a suitable choice for plaque lipid 
detection. To investigate this question, we perform both a simulation and a statistical analysis 
of the frequency content in the range of 1-35 MHz of PA signal obtained from human coronary 
artery plaques ex vivo.  
4 .2 Methods  
4.2.1 Experiment Setup 
The overall schematic of the imaging setup is illustrated in figure 1a. A tuneable laser (Vibrant 
B/355-II, OPOTEK, Santa Clara, CA, USA) served as an optical excitation source for PA 
imaging (pulse width: 5 ns, repetition rate: 10 Hz, and energy per pulse at 1200 nm wavelength: 
2 mJ). A tapered multimode optical fibre (Oxford Electronics, Four Marks, UK; input diameter: 
1 mm, output diameter: 360 µm) coupled the laser light to a custom built forward looking 
optical probe for light delivery (fiber core diameter: 400 um). A needle hydrophone 
(Hydrophone 1875, Precision acoustics Ltd, Dorset, UK) calibrated from 1 MHz to 20 MHz 
and a polyvinylidene difluoride (PVDF) focused transducer calibrated from 10 MHz to 35MHz 
received the PA signals. Combining these two broadband receivers, a large frequency range 
(1-35 MHz) was covered. We will refer to the hydrophone as the low frequency (LF) probe 
and the PVDF transducer as the high frequency (HF) probe in the rest of this manuscript. A 
holder with a window size of 5 x 5 mm held the artery samples. The received signal level was 
optimized by the relative positioning of the tissue sample and the ultrasound receivers: the 
tissue sample was positioned in the focus of the HF probe, and approximately 5 mm from the 
LF probe respectively. The sample holder was connected to a motorized translation stage (MP 
63-25-DC, Steinmeyer GmbH & Co. KG, Albstadt, Germany) to scan the samples. The PA 
signals were amplified by a 43 dB amplifier (AU1263, Miteq, Hauppauge, NY, USA) and were 
digitized at sample frequency of 350 MHz by 12-bit data acquisition card (Acqiris DP310, 
Agilent, Santa Clara, CA, USA). 
4.2.2 Phantom measurement 
The sPA imaging on a phantom was performed to study the PA radio frequency spectra of 
intraplaque lipids at different frequency bands. A Polyvinyl alcohol (PVA) phantom (10% wt. 
PVA crystals in demineralized water, 3 freeze/thaw cycles of at least 2h) was prepared with a 
lumen size of 3 mm and a 1.5 mm round by 5 mm deep cylindrical cavity at 500 µm from the 
lumen. The cavity was filled with cholesterol, cholesterol oleate , cholesterol linoleate (Sigma 
Aldrich Co., C8667, C9253 and C0289, respectively) which are dominating the plaque lipid 
composition [27], and a piece of human coronary adipose tissue. The cavity was emptied and 
cleaned each time before placing a new sample. The sPA imaging was performed from 1125 
to 1275 nm wavelengths with a 2 nm steps (in water at room temperature). The PA signals 
were 32 times averaged to improve the SNR.  The reference sPA signals were acquired using 
a transducer with the central frequency of 40 MHz (referred as the very high frequency (VHF) 
probe in the following text) and bandwidth of 50% as in our previous study [28]. These data 
are referred to as reference data since the majority of publications in the field have used 
similarly high frequency IVUS transducers for IVPA applications.  
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4.2.3 Ex vivo measurement 
Ten human coronary arteries were collected at autopsy from the Department of Pathology of 
Erasmus Medical Center (MC), after obtaining consent from the relatives, under a research 
protocol sanctioned by the Medical Ethics Committee of the Erasmus MC (MEC-2007-081). 
The coronary arteries were frozen within 24h post mortem at -80°, and thawed and measured 
several weeks later for imaging. Before the IVPA measurement, the arteries were imaged by 
OCT (C7XR system with Dragonfly catheters; St. Jude Medical, St. Paul MN, USA) to exclude 
any arteries without atherosclerotic plaques. In the end, seven human coronary arteries were 
selected for sPA imaging. The coronary arteries were cut open longitudinally, mounted on the 
holder and submerged in saline solution at room temperature with the lumen side facing the 
optical probe (Fig. 4.1(b)). In this configuration, the PA signals of the adipose tissue reach the 
acoustic probe first.  
sPA imaging was performed at optical excitation wavelengths ranging from 1125 to 1275 nm 
with steps of 2 nm, allowing localization of the plaque region and discrimination between 
plaque lipids and peri-adventitial fat tissue [13, 27, 28]. At each optical wavelength, 32 PA 
signals were collected and averaged to improve the SNR. The sPA imaging was performed on 
at least 5 locations for each artery sample. Then histological analysis was performed on each 
sample where Oil Red O (ORO) staining was applied at the same cross section on the sample 
from which the PA signal was acquired to identify intraplaque lipids and peri-adventitial lipids 
(lipids are stained red in ORO staining) (Fig. 4.1(c)). 
 
Figure 4.1. a) A schematic diagram of experimental setup for sPA imaging; b) Photo of an artery sample mounted on the 
holder; c) Image of a histology slice with Oil Red O (ORO) staining showing lipids in red. The artery samples were placed 
with the lumen side facing the optical probe. 
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4.2.4 Data processing 
The data from the LF probe were filtered from 1 to 15 MHz (-3 dB bandwidth) and the data 
from the HF probe were filtered from 10 to 35 MHz (-3 dB one-way bandwidth), using a 100th 
order zero-phase forward and reverse finite impulse response (FIR) filter.  The PA optical 
spectra were compared with the reference PA optical spectra of plaque lipids and human 
adipose tissue [28], to separate the PA signals by tissue type. The frequency analysis on the PA 
signals of lipid-rich tissues was performed at the optical wavelength where lipids most 
effectively absorb light (e.g. at 1205 nm).   
The PA signals recorded by both LF and HF probes were stitched together by scaling the signal 
received by the HF probe. The scaling factor was calculated as the ratio of amplitudes of the 
PA signals received by the LF probe and the HF probe at the overlapping frequency of 13 MHz. 
Although the probes were calibrated using their transfer function, the stitching was done to rule 
out the effect of the different transducer surface areas. Then the PA signals of the intraplaque 
lipids were Fourier transformed to calculate the main frequency and the percentage of the 
accumulative PA power over the frequency range from 1 to 35 MHz. 
Furthermore, the shapes of the PA optical spectra received by the LF and HF probes were 
quantified and compared to the reference PA optical spectra. Quantification is based on the 
location of the peak in the PA optical spectra and the full width of the optical spectra at 50% 
of the peak amplitude. The latter parameter is referred to as the full width at half maximum 
(FWHM) in the rest of this manuscript. 
4.2.5 Simulation 
In the simulation, we used the MATLAB k-Wave toolbox [29] to simulate the time-domain 
PA signals of the initial pressure source obtained from intraplaque lipids in histology. The 
purpose of this simulation study was to further investigate whether the intraplaque lipid 
structures in our experiments would produce PA signals with main frequencies similar to what 
was obtained in the ex vivo experiments. The initial pressure source was obtained from the 
ORO staining of a human coronary plaque with all lipids stained in red (Figure 1c). First, we 
segmented the lipids using a custom-made filtering method based on the RGB colors of the 
image (segmenting red structures of the image). Then the segmented lipid structures were used 
as an initial pressure input source for k-Wave toolbox to simulate the PA signals. Then, the 
FFT was applied to the simulated PA signal to calculate the frequency response. The 
percentage of the cumulative PA power was calculated and compared with the experimental 
data. 
4 .3 Results  
4.3.1 Phantom measurement 
 
The PA optical spectra of lipids received by the LF probe are compared with the reference 
optical spectra in fig. 4.2. The spectra received by the LF are almost identical with the reference 
spectra for all the lipid samples. The PA optical spectra from plaque lipids have an absorption 
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peak at around 1190 nm and the spectra from adipose tissue have an absorption peak at 1205 
nm regardless of the frequency band in which they are captured.   
 
Figure 4.2. Comparison of photoacoustic (PA) spectra of the cholesterol (a), cholesterol oleate (b), cholesterol linoleate (c) 
and human coronary adipose tissue (d) received with the low frequency (LF) probe (red curves) and the reference spectra (blue 
curves). 
 
4.3.2 Ex vivo measurement and simulation 
An example of the ex vivo sPA image of a coronary atherosclerotic plaque is depicted in fig. 
4.3. The sPA depth profiles acquired with LF and HF probes after laser power correction are 
shown in fig. 4.3 (a, c). The corresponding detailed PA optical spectra at the locations 
indicating by the dots in fig. 4.3 (a) and (c) are presented in fig. 4.3 (b) and (d) 
Comparing the PA optical spectra with the reference spectra [28] (dashed lines in the fig. 4.3 
(b) and (d)), we can separate the PA signal generated from the intraplaque lipids for further 
frequency analyses. The sPA signals correspond to the plaque optical spectra of the same tissue 
sample at depths from 8.8 mm to 9.3 mm with LF probe and 12.2 mm to 12.6 mm with HF 
probe in figure 3. The frequency content of the plaque PA signal and the cumulative PA power 
as a function of frequency are plotted and compared to the simulation results in figure 4. The 
overal powers of the PA signal in the examined frequency band are almost identical in both 
simulation and experiment (fig. 4.4 (b)). In both situations, we see that 80% of the total PA 
power lies below 5 MHz. 
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Figure 4.3. Spectroscopic photoacoustic (sPA) images of a human coronary plaque. The sPA depth profiles acquired with the 
low frequency (LF) probe (a) and the high frequency (HF) probe (c); corresponding PA spectra at the locations indicated with 
the dots in (a) and (c) acquired with the LF probe (b) and the HF probe (d).  Dashed pink lines represent the reference plaque 
spectra and the dashed orange lines represent the adipose tissue spectra. 
 
Figure 4.4. Experimental and computational frequency analysis of intraplaque lipids: a) Amplitude of the photoacoustic (PA) 
signal as a function of acoustic frequency; b) Percentage of the cumulative power over the frequency range of 1 MHz to 35 
MHz. 
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Two thresholds were chosen to characterize the PA radio frequency power spectra of the plaque 
in the frequency range of 1 to 35 MHz, which is 60% and 80% of the total PA power. The same 
frequency analysis and thresholds were applied to all the PA signals of the artery samples 
(n=36). The statistical results are shown in a boxplot in fig. 4.5. With the threshold of 60% 
power, the PA signal falls in the frequency range below 7 MHz for all the samples and below 
4 MHz for 75% of the samples. Increasing the threshold to 80% of the total cumulative power 
will slightly increase the main frequency to 8 MHz except for two outliers.  
 
Figure 4.5. Photoacoustic accumulative signal power of the intraplaque lipids (n=36) as a function of frequency with two 
thresholds: 60% and 80% of the maximum accumulative power over the frequency range of 1 MHz to 35 MHz [median (red 
lines), 25/75 percentiles (box) and 5/95% confidence bands (whiskers), plus outliers (red dots)]. 
 
Fig. 4.6 shows the statistical results on quantified shape of the sPA signals. The location of the 
peak in the PA optical spectra for intraplaque lipids and adipose tissue are plotted in fig.4. 6(a) 
and the FWHM parameters are plotted in fig.4.6 (b). The shapes of the PA spectra of coronary 
plaque lipids acquired by the HF probe are in good agreement with the reference spectra. 
However, when acquired with the LF probe, the mean of FWHM is 1.6 times higher compared 
with the reference spectra.  
 
Figure 4.6. Comparison of photoacoustic (PA) spectral shape of intraplaque lipids and adipose tissue acquired with low 
frequency (LF), high frequency (HF) and very high frequency (VHF) acoustic probes: a ) Peak location in the PA spectra; b) 
Full width half maxima (FWHM) of the PA spectra. The PA spectra acquired by the VHP is the reference spectra.   
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4 .4 Discussion 
 Frequency analysis on the PA signals (n=36) of human coronary intraplaque lipids ex vivo 
revealed that the majority (80%) of the PA signal power lies below 8 MHz for all samples 
except for two outliers. The frequency characteristics of the PA signal could be replicated by 
a simulation based on plaque lipid structures visualized by a histological lipid stain.  
The relationship between the source size and the amplitude and frequency of the PA signal has 
been investigated before to characterise tissue microstructures [19-25, 30].  Although high 
frequency components of the PA signal may be specifically used to visualize microscopic 
spatial information of the absorbers in the medium [18, 19, 21, 31], their magnitude is much 
smaller than the stronger PA signal reflecting the macroscopic structures [16, 19]. Therefore, 
using a transducer that covers the frequency range in which the intraplaque lipids emit most of 
their PA signal significantly (lower than 8MHz in our results) increases the sensitivity of IVPA 
imaging of atherosclerosis plaque lipid. Currently, a transducer with a broad bandwidth to 
cover frequencies lower than 10 MHz and providing high resolution for IVUS imaging is not 
available. In the field of IVUS imaging, dual element transducers have been proposed to 
increase the bandwidth [32-34] . Although dual element transducers have been proposed also 
for IVPA imaging applications, the lower frequency range of the acoustic spectra is still not 
covered: Ji et al. have recently developed an intravascular confocal IVPA catheter with dual-
element identical transducers with centre frequencies of 19 MHz [35, 36]; and Li et al. has 
developed a catheter for 35 and 80 MHz frequencies [35]. These publications prove the 
possibilities of applying similar technologies in fabricating an IVPA catheter with a large 
bandwidth.  
The shapes of the PA optical spectra of coronary plaque lipids acquired by the HF probe are in 
good agreement with the optical spectra reported in the previous publications [28, 37]. 
However, when acquired with the LF probe, these optical spectral shapes are noticeably 
broader while keeping the same peak locations. This broadening of the optical spectra is 
consistent with the complex constitution of the plaque in the vessel wall and has been reported 
before by Allen et al.  [38]. The complex structure of such plaques consist of not only lipids 
but also other constituents such as collagen (with an absorption peak at 1180 nm [39]), calcium 
(with a flat optical spectra [40]). Mixture of these plaque constituents’ optical spectra is more 
pronounced when the PA signals are received with a LF probe because of the larger effective 
spatial kernel in which the detected signal originates. As expected there was no difference in 
the shape of the optical spectra of pure lipid samples for the LF, HF and VHF probes in a 
phantom, supporting the hypothesis that the broadening of the optical spectra acquired by the 
LF probe ex vivo is due to mixing of signals generated by different plaque constitutes other 
than lipids. It has been shown that intraplaque lipids can be detected with a single optical 
wavelength approach (around absorption peak of lipids) [41, 42]. This approach can readily be 
used with a LF probe since the location of the absorption peak of lipids remains the same. 
However, multiple optical wavelengths approach provides a more reliable intraplaque lipid 
detection [28, 43]. If multiple optical wavelength approach with a LF probe is desired, a new 
calibration is required since the shape of the optical spectra of intraplaque lipids can be broader 
if other plaque constitutions are within the effective spatial kernel of the transducer.   
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Catheter prototypes that rely on typical IVUS transducers require a high pulse energy to 
produce sufficiently strong PA signals [44-47]. Video rate imaging requires a pulse rate of at 
least 5-10 kHz per optical wavelength. It means that the optical power delivered to the vessel 
becomes very high, if such pulse energies can even be produced at optical wavelengths that 
generate lipid contrast. The lack of sufficiently fast lasers has hampered translation of IVPA 
imaging to real-time in vivo experiments, and further into clinical applications. We have 
previously shown that by exploiting the relative difference between the IVPA signal strengths 
at only two wavelengths (1718 and 1734 nm), we could successfully detect and differentiate 
between the plaque lipids and peri-adventitial fat in human coronary arteries ex vivo (Wu, et 
al. 2015). However, the sensitivity in capturing the PA signal with low pulse energy is a key 
factor to translate the technology to the clinic. The sensitivity of IVPA catheters can be 
increased by more than 20 dB by matching the frequency response of the receiving transducer 
to the low frequency range, below 8 MHz, that we observed in this study to maintain most of 
the signal power (80% of the PA power). Such a device would enable imaging with lower pulse 
energy, which may open up opportunities for new fast laser sources with moderate output 
power. 
It is known that under the conditions of thermal and stress confinement, the pressure rise in 
tissue for short laser pulses is nearly isotropic. It is followed by a compression at nearly 
constant temperature during propagation of the laser-induced compressive wave into the 
medium, and a transition to a state with negative pressure when the negative reflection from 
the free surface arrives at the detector surface [48] We did not include the effect of the laser 
pulse length (5 ns) on the frequency content of the PA signals in our study since the frequency 
of the 5 ns short pulse falls in the range much higher than the investigated frequency range (up 
to 35 MHz) in this study. 
4 .5 Limitations 
Our statistical analysis were done on a rather small sample size (n=36). Moreover, the arteries 
were donated from non-symptomatic patients with perhaps smaller plaque size compared with 
symptomatic patients. This suggests that the main frequency of the PA signals to be at even 
lower frequencies for patients with bigger fatty structures in larger plaques. Further 
comprehensive investigations are needed to develop a reliable statistical model. Also we did 
not investigate the possible effect of freezing the tissue samples on the optical and acoustical 
properties of their PA signal. Finally, the differences in the exact shape of the acoustic spectra 
of the PA signal (figure 4a) is due to various parameters which are different in experiment and 
simulation such as, the discretization of the input initial pressure source; dimensions in which 
the simulation is performed (2D instead of 3D) and the shape of the lipid droplets after ORO 
staining.  
4 .6 Conclusion 
Based on our frequency analysis of intraplaque lipid photoacoustic signals, it is expected that 
the sensitivity of intravascular photoacoustic imaging for intraplaque lipids will be 
significantly improved if ultrasound transducers with large bandwidth which covers the lower 
frequencies (1-10 MHz) are used.  
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Abstract  
 
Lipid deposition can be assessed with combined intravascular photoacoustic/ultrasound 
(IVPA/US) imaging. To date, the clinical translation of IVPA/US imaging has been stalled by 
a low imaging speed and catheter complexity. In this paper, we demonstrate imaging of lipid 
targets in swine coronary arteries in vivo, at a clinically useful frame rate of 20 s-1. We 
confirmed image contrast for atherosclerotic plaque in human samples ex vivo. The system is 
on a mobile platform and provides real-time data visualization during acquisition. We achieved 
an IVPA signal-to-noise ratio of 20 dB. These data show that clinical translation of IVPA is 
possible in principle. 
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5.1 Introduction  
Cardiovascular diseases (CVDs) are the leading cause of death worldwide. In 2012, 17.5 
million people died from CVDs, representing 31% of all the global deaths. Particularly, 42% 
of these CVD deaths are due to coronary artery disease (CAD), which is most often triggered 
by the rupture of vulnerable atherosclerotic plaque and ensuing thrombosis [1, 2]. A vulnerable 
plaque is commonly described as a lipid-rich necrotic core, covered by a thin fibrous cap with 
macrophage infiltration [3]. These plaques have been implicated in worse short-term and long-
term outcomes of coronary interventions, as they may destabilize by intracoronary 
instrumentation during the intervention, or spontaneously at a later stage. The identification of 
the vulnerable plaque requiring information on the structure and composition of the plaque [4], 
can have an important role for guiding the diagnosis and treatment of CAD.  
All commercially available intravascular imaging modalities can detect one or more of the 
defining features of a vulnerable plaque, but none provides conclusive identification [5]. 
Intravascular optical coherence tomography is well positioned for imaging fibrous cap 
thickness but has insufficient imaging depth to fully visualize the artery wall [6], and tissue 
characterization requires a high level of user expertise [7]. Intravascular ultrasound (IVUS) can 
usually see the entire vessel, but lacks resolution and soft tissue type specificity. This has led 
to the proposal of multimodal imaging strategies [8]. Optical spectroscopies are ideal for 
discriminating between tissue types, capitalizing on specific absorption features [9, 10]. IVUS 
has been combined recently with near-infrared spectroscopy (NIRS), which provides 
information about the presence of lipid-core plaque, but still is unable to measure its depth 
relative to the lumen border [11].  
Combined intravascular photoacoustic (IVPA) and IVUS imaging is emerging as a promising 
technology for localization, characterization and quantification of coronary atherosclerotic 
plaque lipids. IVPA imaging, generating ultrasound signal by the absorption of a short laser 
pulse in the tissue, is capable of imaging the composition of the artery wall with an adequate 
imaging depth and resolution based on the optical absorption contrast between different tissues 
[12, 13]. Tissue contrast in IVPA can be chosen by tuning the excitation wavelength to a 
specific absorption band of the imaging target. We target atherosclerotic plaque lipid, the most 
prevalent marker for identifying vulnerable plaques, by choosing an excitation wavelength that 
excites a PA signal from lipids [12, 14-17], and ideally from atherosclerotic lipids alone [18-
20]. Its co-registered IVUS image provides the complementary structure information of the 
artery wall. Although IVPA/US imaging potentially offers valuable information for assessment 
of plaque vulnerability, the slow imaging speed and the difficulty in design and fabrication of 
a miniature flexible catheter have presented as major challenges for translation of IVPA/US 
imaging into an in vivo or clinical application. An intensive research effort is ongoing towards 
the further development of IVPA/US imaging systems. Imaging speed is primarily limited by 
laser pulse rate: with the introduction of 500 Hz to 2 kHz repetition rate laser systems, operating 
at the wavelengths of lipid absorption peaks near 1.2 µm or 1.7 µm, the IVPA/US lipid imaging 
speed has recently increased to about 1 frame per second (fps) [21-23]. Use of a more 
conventional laser wavelength facilitates speed but offers limited biological image contrast 
[24]. 
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The routine for intravascular imaging is to perform a pullback while acquiring a series of cross-
sectional images, which together form a volume scan. If using the closest relative, IVUS 
imaging, as a reference, scanning a vessel with a pullback speed of 0.5-1 mm/s and a frame 
rate of 20-50 fps is required for IVPA imaging.  
In this paper, we demonstrate an IVPA/US system with a 1.3 mm outer diameter flexible 
catheter, imaging coronary lipids at the speed of 20 fps, comparable to the speed of a 
conventional commercial IVUS system [25, 26]. This frame rate is the minimum usable 
acquisition speed for in vivo volumetric (pullback) imaging, if adequate sampling is required 
in the presence of cardiac motion. We demonstrate the imaging performance in vivo in a 
healthy swine model with an introduced lipid target, and on a human atherosclerotic coronary 
artery sample ex-vivo. 
5.2 Methods and materials 
5.2.1 IVPA/US image acquisition and real-time visualization 
The schematic of the high-speed IVPA/US imaging system is shown in fig.5.1.The laser source 
in the system (FQ-OPO, Elforlight Ltd, Daventry, UK) is a periodically-poled LiNbO3 OPO 
pumped by a pulsed Nd:YAG laser, which in turn is pumped by a CW diode. The laser pulse 
duration is approximately 10 ns, the maximum output pulse energy of the laser is 80 µJ/pulse 
and the pulse repetition rate is of 5 kHz. The tuning range of the laser is from 1700 to 1750 nm. 
The laser output is coupled into a multimode optical fiber with a core diameter of 100 µm and 
connected to the 1.3 mm IVPA/US catheter through an optical rotary joint (Princetel, Hamilton, 
NJ, USA) and an electrical slip ring (LPT025, JINPAT Electronics, Shenzhen, China) inside 
the scanning stage. The IVPA/US catheter is based on the design we previously described in 
[27], consisting of a 100 µm diameter angle polished fiber (angled at 34 degree, low OH, 
Pioneer Optics, USA), an ultrasound transducer element (40 MHz central frequency, 50% 
bandwidth, Blatek, USA), a tip assembly made from polyether ether ketone (PEEK), a metal 
torque coil and a 1.3 mm outer diameter polyethylene (PE) sheath. An ultrasound pulser (AVL-
2-PS-P, Avtech Electrosystems Ltd, New York, NY, USA) is used to transmit 80 V amplitude 
pulses for pulse-echo imaging. A pulse/delay generator (BNC model 575, Berkeley Nucleonics 
Corporation, San Rafael, CA, USA) provided timing and triggering signals to the laser, 
digitizer and the ultrasound pulser. The time delay between the PA and US signal is 10 µs. The 
received data were 43dB amplified (AU1263, MITEQ, Long Island, NY, USA), band pass 
filtered (13–60 MHz 5th order Butterworth, custom built), digitized and transferred by a data 
acquisition card with 14 bits digitization and 400 MS/s sampling rate (PX14400, Signatec, New 
York, NY, USA) installed in a personal computer (PC). The data acquisition software was 
developed in C++ (Microsoft Visual Studio 10) to acquire and display the recorded data in real 
time. Simple data processing including decimation, truncation, absolute value, normalization, 
and scan-conversion to Cartesian coordinates was applied to the acquired data before real time 
data display. A video of data acquisition and visualization with the software interface is 
provided in Visualization. 1. Rotation (313518, Maxon motor, Sachseln, Switzerland) and 
translation motors (143967, Maxon motor, Sachseln, Switzerland) were combined for helical 
scanning, driving the catheter rotation at 1200 rpm and pullback at 0.1~1 mm/s. One cross-
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sectional image was composed of 250 A-lines and the whole system is capable of IVPA/US 
imaging at 20 fps. All the devices were placed in a portable trolley for easy transportation. 
 
 
Figure 5.1. Real-time IVPA/US imaging system. (a) Photo of the mobile IVPA/US system.  (b) Schematic of the IVPA/IVUS 
imaging system composition and illustration of the IVPA catheter components. (c) Photo of the pullback unit. (d) Data 
acquiring and display with the homemade software interface on a human coronary artery sample ex vivo (Visulization 1) 
 
5.2.2 Data processing 
Further signal processing on the data was performed in Matlab (R2016a; The Mathworks, 
Natick, MA, USA) offline. All received PA and US data were decimated, digitally band pass 
filtered from 10 to 60 MHz, envelope filtered, median filtered, denoised and converted for 
display as in our previous work [12]. In the in vivo data, we noticed image wobble in the 
pullback due to variations in tip rotation speed, possibly related to cardiac motion. We applied 
a global rotational block matching correction based on the correlation of subsequent IVUS 
frames [28]. After this motion correction, we enhanced the PA signal to noise ratio (SNR) by 
averaging each A-line in a 3×2 (lines×frames) averaging kernel. For instance, the PA signal 
at 𝑖𝑡ℎ A-line and 𝑗𝑡ℎ frame, 𝑃𝑖,𝑗, was averaged with its two adjacent A-line signals at the same 
frame 𝑃𝑖±1,𝑗 and the PA signal at the same three A-lines in the next frame, 𝑃𝑖±1,𝑗+1. 
Furthermore, in vivo imaging is performed through the PE sheath, which attenuates PA signal 
and introduces strong reflection artifacts. The reflection artifacts are highly correlated 
throughout the pullback recording. The reference reflection artifact PA signal was constructed 
from the PA images without lipid target and was used to cancel the artifacts in images with 
lipid target. 
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5.2.3 Human coronary artery sample preparation 
One artery sample (LAD, 48 years old man) was collected at autopsy from the Department of 
Pathology of Erasmus Medical Center (MC), after obtaining consent from the relatives. The 
research protocol was sanctioned by the Medical Ethics Committee of Erasmus MC (MEC-
2007-081). The coronary artery was frozen within 2h after autopsy and stored at -80° until 
analysis a few months later. Prior to analysis, the artery was thawed and measured within 
several hours. In the measurement, metal needles were used to fix the artery specimen inside a 
small container filled with D2O-saline and register the pullback locations. Figure 2(a) shows a 
photo of the prepared artery sample for the measurement. The IVPA/US measurement was 
performed at room temperature at the wavelength of 1720 nm. To maximize the PA SNR, the 
PE sheath was removed during the measurement. 500 frames data were acquired for one 
pullback and the pullback speed was set to be 0.1mm/s. All the IVPA/IVUS images were non-
averaged.  
After the measurement, we cut the part of the artery sample imaged, embedded in optimal 
cutting temperature compound (Tissue-Tek®, Sakura Finetek Europe B.V., Alphen a/d Rijn, 
The Netherlands), and stored it at -80°C until further processing. For histology, we sliced the 
whole frozen artery block into a series of 10 µm thick sections. Oil Red O (ORO) staining was 
applied to all these sections to detect lipids.  
5.2.4 In vivo IVPA/US imaging in swine coronary lipid model 
To further test the imaging system, an in vivo IVPA/US experiment was performed on a healthy 
farmbred (Yorkshire-landrace) swine. The animal was sedated using Zoletil 100 (Virbac 
Nederland BV, Barneveld, The Netherlands), Sedazine (AST Farma BV, Oudewater, The 
Netherlands) and Atropine (Pharmachemie BV, Haarlem, The Netherlands), and anesthesia 
was maintained using pentobarbital (10-15 mg/kg/hr) while connected to a ventilator as 
described before [29]. The protocol was approved by the Erasmus MC Animal Ethics 
committee and was performed in accordance with the Guide for Care and Use of Laboratory 
Animals [30]. Following anesthesia and a surgical cut-down, a sheath was introduced into the 
carotid artery. Then a guiding catheter was advanced to the right coronary artery (RCA) for 
stent placement and intravascular imaging. Under guidance of angiography a small piece of 
pork lard was delivered into the coronary artery to mimic the plaque lesion as described by 
Lovrak et al [31]. The pork lard (lipid target) was fixed at its two ends with two small, modified, 
double-layered stents on the balloon catheter (Pantera Pro 4.0/15; Biotronik SE & Co. KG, 
Berlin, Germany). Figure 5.3(a) shows the photo of the lipid rich material with stents mounted 
on the balloon catheter. To prevent the two stents from being pushed apart while inflating the 
balloon, we connected them with the black surgical wires.  
Then, the IVPA/US catheter was advanced into the RCA with a GuideLiner catheter (6F, 
Vascular Solutions, Minneapolis, MN, USA). The metal stents and the catheter were radio-
opaque, thus, the pullback locations could be easily tracked by X-ray imaging [Fig. 5.3 (b)]. In 
this way, IVPA/US pullback recording was arranged to cover the lipid target region (the region 
in between the two stents) at a speed of 0.5mm/s. Each pullback recording contains at least 200 
frames. The in vivo experiment was also performed at 1720 nm, but unlike the ex vivo 
experiment, it imaged through the PE sheath. During the experiment, we continuously flushed 
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the artery with heavy water-based saline. After the experiment, we sacrificed the pig, cut the 
artery open and confirmed the presence of the lipid target inside the RCA.  
 
5.3 Results 
5.3.1Ex vivo IVPA/US imaging of human coronary artery  
We imaged a human atherosclerotic plaque specimen, obtained from autopsy. Figure 2 shows 
the combined IVUS/IVPA data. An atherosclerotic lesion with a variable amount of intraplaque 
lipid, photographed in its holder in Fig. 2(a), is visualized by IVPA/US. The lipid content 
increases in the pullback direction, from left to right in Fig. 2(b), appearing from 3 o’clock to 
7 o’clock in the 3D reconstruction of the pullback data. Histology validations by Oil Red O 
lipid stain are shown at two pullback locations, indicated with yellow and blue contours in Fig. 
2(b). In the combined IVPA/US images [Fig. 2(c) and 2(e)], the IVPA signal can be clearly 
appreciated at the corresponding thickened intima region within the artery wall (from 2 o’clock 
to 7 o’clock). This suggests the presence of a lipid-rich plaque, an observation that is confirmed 
by comparison with the histology. The proximal location [Figs. 2(c) and 2(d)] shows a bright 
IVPA signal corresponding to a dense lipid-laden intima. The more distal location [Figs. 2(e) 
and 2(f)] exhibits a markedly lower IVPA signal, and a less extensive lipid infiltration on 
histology. 
IVPA achieved full visualization of the lipid-rich lesion throughout the depth of the plaque. 
The signal-to-noise ratio (SNR) of the PA signal in the plaque region in the image is 
approximately 20 dB without any averaging, validating the capability of plaque visualization 
with enough imaging depth by IVPA imaging at 1.7 µm in coronary artery.  
 
Figure 5.2. IVPA/US cross-sectional image of an atherosclerotic human coronary artery. (a) Photo of the human LAD sample fixed inside a 
holder. (b) 3D reconstruction of the pullback IVPA/US images. (c) Merged IVPA/US image of the plaque at locations with large plaque 
volume (the location with a yellow contour) and (e) with small plaque volume (the location with a blue contour). (d) and (f) The ORO histology 
staining at the imaging plane corresponding to  images of (c) and (e). The dynamic range is 35 dB in IVUS image and 20 dB in IVPA image. 
No averaging was applied to IVUS or IVPA data. 
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5.3.2 In vivo IVPA/US imaging of swine coronary artery 
In vivo IVPA/US imaging of a swine coronary artery with an artificial plaque is shown in Fig. 
5.3. A lipid target was introduced into the coronary artery of a healthy animal by attaching a 
piece of pork fat to a pair of coronary stents and deploying them to attach it to the vessel wall 
[Fig. 3(a)]. Stents were introduced on a balloon under angiography guidance [Fig. 5.3(b)]. We 
acquired a pullback data set using the experimental IVPA/US catheter and system. A 
longitudinal section of the pullback IVPA/US data containing the lipid target is shown in Fig. 
5.3(c), along with cross-sectional images at two selected pullback locations; one inside the lipid 
region (yellow line) and the other one outside (blue line). The lipid target can also be seen in 
the IVUS images as an intraluminal, echogenic object, and this was used to delineate the target 
by the dotted contour in Figs. 5.3(c) and 5.3(d). In the IVPA/US images of the lipid target 
[Figs. 5.3(d)-3(f)], a bright PA signal at 6 o’clock to 9 o’clock inside the lumen, generated from 
the lipid, is clearly observed with an SNR≈18 dB (marked with a yellow contour). As a 
reference, the characteristic PA signal disappears in absence of the lipid target; remaining 
signal is concentric with the catheter and is attributed to artifacts arising from signal generation 
in the catheter sheath. The entire IVPA/US pullback data display (300 frames data) video is 
shown in Visualization 2. 
By IVUS, the lipid target appears larger than by IVPA: the IVPA does not detect the entire 
lipid inclusion. We attribute this to a combination of catheter limitations and image processing: 
During imaging, the target did not align perfectly with the artery wall, as expected, and as a 
result was very close to the catheter [Fig. 5.3(d)]. As described in our previous work [27], an 
IVPA catheter with a longitudinal beam offset has a low sensitivity to targets that are in close 
proximity to the transducer due to small optical/acoustic beam overlap. Secondly, imaging 
artifacts originating from light absorption in the catheter sheath overlapped with the lipid 
signal. Additional data processing to suppress the artifacts partially suppressed the lipid signal, 
while some residual artifacts remained, indicated with white arrows in Fig. 5.3(e). 
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Figure 5.3. In vivo IVPA/US imaging result on a swine model. (a) Stents with lipid target mounted on a balloon catheter. (b) 
X-ray imaging of the pullback location. The stents were inside the yellow boxes and the lipid target located in between the 
two stents. (c) Longitudinal view of the pullback merged IVPA/US data at an angle intersecting with the lipid object (indicated 
with a purple line in (d)). (d,e,f) Cross-sectional IVUS, IVPA, and merged IVPA/US image at the pullback location indicated 
with a yellow line in (c). (g,h,i) Cross-sectional IVUS, IVPA and merged IVPA/US image at the pullback location indicated 
with a blue line in (c).The dynamic range is 32 dB for IVUS images and 18 dB for IVPA images; scale bar in (f) applies to all 
of (d)-(i). 
 
5.4 Discussion 
In this work, we demonstrated in vivo IVPA/US imaging based on a system using a 5 kHz laser 
with a flexible 1.3 mm catheter, capable of volumetric lipid detection in coronary arteries at 20 
frames per second. We validated the imaging system performance on a human coronary artery 
ex vivo and on a swine coronary artery in vivo. It is the first in vivo IVPA/US imaging in a 
coronary artery reported to date, acquiring images of coronary lipid in this highly mobile, 
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challenging environment. Our IVPA/US imaging system significantly increased the imaging 
speed from 1 fps (the fastest imaging speed reported so far for a lipid-imaging IVPA system) 
to 20 fps [21-23, 32]. The operating parameters of our implementation of this technology match 
those desired of a clinical imaging system in terms of acquisition speed, operating wavelength, 
and scan method. The catheter proved to be sufficiently robust for in vivo imaging. Further 
miniaturization of the device is possible and has been demonstrated [32, 33]; the outer diameter 
could be reduced to < 1 mm with a smaller torque coil and outer sheath. 
The IVPA/US system performs acquisition and real-time display of dual-modality data, 
meaning the data is visualized during imaging at the same rate that it is acquired. This is a key 
step for usability of IVPA in real-world settings. The image optimizations we performed off-
line in the in vivo experiments do not require user intervention and could be incorporated 
straightforwardly in the real-time visualization (inducing a one-frame display delay). 
The laser source in our system has a high repetition rate but moderate pulse energy. Partially 
due to ineffective coupling and scattering at the catheter tip, the optical exposure is less than 
0.4 J/cm2 at 1.7 µm, which is below the 1 J/cm2 threshold specified by the ANSI laser safety 
standard [22]. Despite using a pulse energy which is one order of magnitude lower than that 
used previously in IVPA/US systems working at 1.7 µm, the PA SNR achieved in our imaging 
system was 20 dB, comparable to earlier reports [22, 23].  We used pork lard as a lipid target 
for in vivo imaging, which has a different lipid composition, and thus a slightly different 
absorption spectrum, compared to lipid-rich plaque [20]. However, at the selected wavelength 
(1720 nm), both pork lard and plaque generate strong PA signals. An alternative synthetic 
plaque is being developed, containing the same types of lipids as in plaques to better mimic the 
plaque lipid signature [31]. This material can be introduced in a similar manner as we did in 
the present study.    
Some challenges clearly remain for the clinical translation of IVPA/US imaging, particularly 
in the catheter design. In a typical miniature non-collinear IVPA catheter, the offset between 
the acoustic and optical beams, longitudinally or laterally, leads to a low PA SNR when targets 
are close to the transducer [27]. Collinear catheter designs do not face this problem, but are 
more prone to image artefacts resulting from near-field optical absorption [34]. Another 
difficulty in catheter design is the sheath material, which needs to be transparent for both 
ultrasound and light (at 1.7 µm). The polyethylene (PE) material in our current catheter sheath 
is abundant in C-H bonds as lipids, which makes it a strong absorber at wavelengths providing 
lipid-specific contrast. A PE sheath absorbs almost half of the PA excitation energy, leading to 
a reduction in PA SNR and strong reflection artefacts due to echoes of the sheath-generated 
signal in IVPA image (fig. 5.5). Especially, during the in vivo swine experiment, the artifact 
from PE sheath appears close to the lipid target, making the PA signal from lipid target a 
mixture with sheath artifact, which is difficult to completely cancel without losing PA signal 
originating from tissue. A direct comparison between images with and without sheath shows a 
similar reduction in PA energy [24]. 
Attenuation and artifacts affect the quality of in vivo IVPA images compared to the ex vivo 
IVPA results, collected without sheath. Fluorinated polymers, such as PTFE are an interesting 
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alternative, but tend to have suboptimal mechanical and acoustic properties in their crystalline 
forms. Fabrication of amorphous fluorinated polymer, such as perfluoro-3-butenyl-vinyl ether 
(CytopTM), which is flexible and has a 95% transmittance of the light at  1.7 µm [35], in tube 
form would make these promising materials available for evaluation as catheter sheaths.  
        
Figure 5.4. in vivo IVPA/US pullback recording (300 frames data) of a swine coronary artery with an artificial plaque lesion 
(Visualization 2). 
 
 
Figure 5.5. Merged cross-sectional IVPA/US image of the in vivo result on a swine coronary artery with artificial plaque lesion. 
White arrow indicates the PE sheath artifact, yellow arrow indicates the black surgical wire and blue arrow indicates the 
mixture of lipid signal and PE sheath artifact. 
 
 
 
Fast and stable laser systems are also essential for translation of IVPA/US imaging to the 
clinical setting. We need to strike a balance between pulse rate (for speed), pulse energy (SNR), 
and overall power delivered to the vessel (safety). As 1.7 µm radiation is strongly absorbed by 
water, it is considered an eye-safe wavelength, which reduces concerns for user safety. We 
have not seen evidence of laser tissue damage in our human or swine samples, upon deposition 
of 150 mW of light in the artery. Nevertheless, optically and acoustically efficient designs 
allow for minimization of the applied laser power while preserving SNR. In recent work[36], 
we found that 80% of PA power from lipid-rich plaque is at frequencies below 8 MHz, and the 
PA SNR can be increased up to 20 dB by covering the frequency band below 8 MHz. We 
experienced >50% optical loss due to fiber coupling and scattering in the tip optics, which is 
clearly suboptimal. Improved catheter design and functionality may enable IVPA lipid imaging 
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with lower laser pulse energy and output power. Such moderate-output power lasers may prove 
to be more robust, user-friendly and affordable than the complex OPO system we currently use. 
In the present series of experiments, we have chosen to clear blood from the artery for 
optimizing PA SNR. It is possible to image lipids through blood at 1.7 µm by IVPA imaging 
[16] due to the relatively small scattering coefficient at infrared wavelengths[37]. H2O 
absorption is significant, both in blood and in saline flush, which is why we use D2O-saline 
for flushing. Heavy water is non-toxic but expensive, which may present as a limitation going 
forward. 
In summary, we demonstrated volumetric in vivo IVPA/US of lipid in the coronary circulation 
of a healthy swine.  We built an imaging system with a miniature flexible catheter, allowing to 
image lipid-rich plaque lesions at 20 fps. The system produces good IVPA/US images of lipids 
with a PA SNR of about 20 dB at the an imaging frame rate that is compatible with 
comprehensive pullback imaging of coronary plaques. 
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As coronary artery disease (CAD) is one of the leading causes of worldwide death, and brings 
substantial health care and economic burden to the society, intensive research effort has 
focused on it. The first clinical manifestation of CAD is commonly acute coronary syndrome 
(ACS) which is most often triggered by the rupture of the vulnerable atherosclerotic plaque 
and thrombosis [1-3]. A vulnerable plaque is generally represented as a lipid-rich necrotic core, 
covered by a thin fibrous cap with macrophage infiltration [4]. The knowledge of these features 
of the plaque is very important to characterize the vulnerability of the plaque, and thus is very 
helpful for guiding the diagnosis and treatment of CAD. 
Intravascular photoacoustic (IVPA) imaging, generating an acoustic signal by specific optical 
absorption of the tissue, can image different tissue types with a good resolution (~50 µm) and 
reasonable imaging depth based on optical absorption contrast in coronary artery wall [5-7]. 
By working at different optical wavelengths for different absorption targets, IVPA imaging is 
capable of detection of many compositions present in a vulnerable plaque [8-10], with a 
primary focus on IVPA imaging of the lipid-rich core [11, 12]. A co-registered IVUS image 
offering full visualization of the artery wall structure is born with IVPA imaging by sharing 
the same ultrasound transducer. The combined IVPA/US imaging is able to image the 
atherosclerotic vulnerable plaque, morphologically and compositionally [13], making it a 
useful tool for assessment of the risk of the plaque lesion.  
The complexity of the design and fabrication of the imaging catheter, and the slow imaging 
speed have impeded the translation of IVPA imaging to a clinical setting to date. In the recent 
years, research efforts have been directed towards the realization of a clinically feasible IVPA 
imaging system.  We have achieved several essential steps on the way of translation of IVPA 
imaging to clinics:  the miniature flexible catheter, high-efficiency specific imaging of 
vulnerable plaque composition, and a real-time IVPA imaging system (~ 20 frames per 
second). This chapter discusses an overview of our work and some remaining challenges on 
the development of IVPA imaging.  
6.1 Achieved steps towards clinical IVPA/US imaging system 
6.1.1 Steps towards a miniature IVPA catheter 
A practical, functional IVPA/US catheter requires miniaturization to a size of less than 1 mm 
and high sensitivity for PA detection. Several layouts of the optical and acoustic channels of 
the catheter are possible, and have been characterized in literature by different research groups. 
A catheter design with a longitudinal offset between the optical and the ultrasound beams, 
which is used in the smallest IVPA catheter (diameter is 0.9 mm) reported so far [14],  appears 
to be the best candidate for miniaturization. Based on this catheter design, we fabricated a 
flexible IVPA/US catheter with an outer diameter of about 1.3 mm, which is capable of lipid 
imaging in coronary arteries ex vivo and in vivo. A comprehensive characterization of the 
imaging property of the catheter is important for interpreting the received images. The spatial 
resolution of the catheter was quantified by a measurement on isolated targets. With our 
catheter, the PA and US axial resolutions are 52 and 43 µm, the lateral (azimuthal) resolutions 
are 215 and 205 µm, while the longitudinal (in the pullback direction) resolutions are 500 and 
205 µm, respectively. The geometry configuration in our catheter presents a curved PA point 
Chapter 6. General Conclusion 
 77 
spread function in space, resulting in a mismatch between PA and US imaging plane. This 
mismatch is reduced in the presence of optical scattering, which is natural in tissue (Chapter 
2).  
6.1.2 Steps towards specific plaque lipids identification by IVPA imaging 
To visualize the lipid deposits in atheromatous plaque, IVPA imaging generally works at the 
wavelength where lipids are the most highly absorbing tissue components. The optical 
absorption spectrum of lipids is shown in fig. 1(a). Generally, 1.2 or 1.7 µm are the best and 
most commonly used optical wavelengths for imaging lipids, although the possibility of IVPA 
imaging of lipids at 760 or 1064 nm has been explored [15, 16]. Compared to the other reported 
wavelengths for lipid imaging in  coronary arteries, 1.7 µm has several advantages: it has a 
higher lipid-specific optical absorption and lower attenuation through biological tissue (fig. 
6.1(b)) [17]; because of strong water absorption at this wavelength, it is considered eye-safe, 
which takes care of a major user safety concern. Fig. 6.1(c) shows the PA absorption spectra 
of lipid in water. Normalized the PA spectra amplitude of lipid to the one measured at the water 
interface (no water path), through about 3 mm water path, which is deep enough for imaging 
coronary arteries, the PA SNR of lipid at 1.7 µm is about 5 dB higher than imaging at 1.2 µm 
[18, 19].  
 
Figure 6.2. (a) Lipid absorption spectrum. The absorption spectra of water (solid line) and human fat (dotted line), with red 
dashed boxs indicating the two absorption peak for lipids. Adapted from [20]. (b) Attenuation length of brain tissue, showing 
the dominant contributions of tissue scattering in the visible/NIR region (up to approx. 1.3 µm), and of water absorption at 
longer wavelengths. Adapted from [17]. (c) The absorption spectra of lipid through different water path. 
Typically, lipids are found in the plaque inside the artery wall (rich in cholesterol and 
cholesteryl esters [21, 22]), as well as in peri-adventitial fat tissue around the artery (a mixture 
of fatty acids [23]). These different lipids present different PA spectra, and can be differentiated 
by spectroscopic IVPA imaging (sIVPA)[24, 25]. However, sIVPA imaging requires many 
wavelengths and makes the imaging system complicated and costly. To solve this problem, we 
developed a new algorithm to detect and differentiate between plaque lipids and peri-
adventitial fat with two wavelengths only, specifically 1718 and 1734 nm. Statistically, we 
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identify 70% of lipids in plaques, and 15% in the peri-adventitia tissue as cholesterol-like 
lipids. The latter number represents actual false positives. The former score is defined as a true 
positive detection and may be underestimated by the variability of plaque lipid composition: 
Plaques also contain fatty acid-like lipids (e.g. triglycerides and phosphatidylcholines). With 
this method, the presence and location of lipids within a plaque can be reliably and quickly 
displayed during a catheter pullback recording. Importantly, the specific information based on 
the spectral analysis is rapidly available without the need of tedious examination of the IVUS 
information. However, the recalibration of the threshold parameter is required when adapted 
the algorithm to different IVPA/US imaging systems (Chapter 3). 
6.1.3 Steps towards a fast and safe IVPA/US imaging system 
As a powerful tool to image lipid-rich vulnerable plaques, the further development of IVPA 
imaging severely suffers from its low imaging speed mainly due to the slow laser system. With 
the introduction of the fast lasers with 500 Hz to 2 kHz pulse-rate, many fast IVPA imaging 
system are on horizon [14, 26-28]. Although the imaging speed of IVPA imaging system for 
lipid imaging has been increased to 1 frame per second [27, 28], it is still too slow and restricts 
the application of IVPA/US imaging to the laboratory setting only.  If taking clinically 
available IVUS system as a reference (IVUS system scans a vessel with a pullback speed of 
0.5-1 mm/s at a frame rate of at least 20 fps [29]), an IVPA/US imaging system suitable for 
clinical applications requires a minimal frame rate of 20 fps. To reach 20 fps with a minimal 
150 A-scan per cross-sectional acquisition (our catheter has an angular resolution about 5 
degree, with a minimal 50% angular overlap between adjacent A scan, it requires more than 
360 144
5*0.5
  A-scan per cross-sectional acquisition), a laser system with a pulse rate of at 
least 3000 (20*150) Hz is necessary. 
We developed a real-time IVPA/US imaging system based on a 5 kHz OPO laser system 
(tuning range: 1700 to 1750 nm, pulse energy: maximal 80 µJ/pulse) and a flexible 1.3 mm 
imaging catheter. This IVPA/US imaging system is capable of imaging at 20 fps (250 A-scan 
per cross section), which is 20 times faster in terms of frame rate than any other imaging 
system, reaching the minimum acceptable imaging speed of commercially available IVUS 
systems, as routinely used in clinics for intracoronary imaging. The capability of the IVPA/US 
imaging system was first validated by the high accordance of the ex vivo result on an 
atherosclerotic human coronary artery to the gold standard histology staining. Encouraged by 
the success in the ex vivo experiment, we achieved the first in vivo IVPA/US imaging of 
coronary arteries on a healthy swine with an artificial plaque lesion.  
In both the ex vivo and in vivo experiments, the real-time IVPA/US imaging system achieved 
a PA signal from the lipid deposition in coronary arteries with a SNR around 20dB  based on 
the laser source with a high repetition rate but moderate pulse energy, which is about 10 times 
lower than the other imaging systems [27]. Due to ineffective coupling and scattering at the 
catheter tip, the optical exposure is less than 0.4 J/cm2 at 1.7 µm, which is below the 1 J/cm2 
limit specified by the ANSI laser safety standard [28, 30].  In all the measurements, we have 
not seen any evidence of laser tissue damage in our human or swine samples, upon deposition 
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of 150 mW of light in the artery. These results demonstrate the capability of the IVPA/US 
imaging system for in vivo application (Chapter 5).  
As argued above, faster imaging or more wavelengths can only be achieved by raising the laser 
system’s pulse rate. The average power increases linearly with pulse frequency. With further 
increase of the laser repetition rate (> 10 kHz) while maintaining a reasonable pulse energy for 
high PA SNR (> tens µJ/pulse out of catheter), the average power delivered to the artery for 
IVPA imaging is quickly running into power management and safety concerns As one possible 
solution for that, it is important to match the transducer frequency bandwidth to the frequency 
response of PA signal generated from the plaque. Based on analysis of in vitro IVPA data from 
several atherosclerotic human coronary artery specimens, we found that that 80% of the PA 
power generated from plaque lipids lies in the frequency band below 8 MHz. The PA SNR can 
be increased by an order of magnitude by covering the low frequency range. The finding may 
enable the possibility of IVPA imaging based on fast laser sources with a moderate output 
power (Chapter 4). 
6.2 Future works towards clinical IVPA/US imaging system 
Although our current IVPA/US imaging system is capable of in vivo plaque lesion analysis, 
many challenges clearly remain for the further development of IVPA/US imaging. An ideal 
IVPA/US imaging system would consist of a highly sensitive imaging catheter with a 
maximum outer diameter of 1 mm, the robust, compact, fast laser system working at two 
different wavelengths for plaque lipid specific imaging, and a software interface capable of 
rapid visualization of the presence and location of lipid-rich plaque during the pullback data 
acquisition. The imaging system would allow for plaque imaging at a frame rate of at least 20 
fps with a safe optical output power (below the threshold of 1J/cm2 at 1.7 µm) 
6.2.1 Catheter design 
Based on the longitudinal dual beam offset design, the current prototype of flexible IVPA/US 
imaging catheter is 1.3 mm in outer diameter. The size of the catheter can be further reduced 
to around 1.0 mm by replacing with a smaller metal torque coil and outer sheath. However, 
this catheter design has a poor PA sensitivity with imaging targets close by the catheter. A 
collinear IVPA/US catheter design is proposed recently to overcome this limitation[31]. The 
design optimizes the imaging sensitivity and imaging depth with a highly overlapped dual 
beam path, but it is more prone to image the artifacts resulting from near-field optical 
absorption, such as the artifacts from the catheter sheath. Especially the catheter outer sheath 
is currently one of the biggest challenges for IVPA/US imaging. The sheath material needs to 
be transparent for both ultrasound and light (1.7 µm), as well as be strong enough to support 
the catheter inside the coronary arteries. In current prototype catheter, a PE sheath is used, 
which has adequate ultrasonic properties but attenuates the excitation light, leading to a 
reduction in PA SNR and strong reflection artifacts. Amorphous fluorinated polymers, such  as 
perfluoro-3-butenyl-vinyl ether (CyTopTM), which is flexible and has a 95 % transmittance of 
the light at 1.7 µm [32], may be a promising choice as the catheter sheath.  
As mentioned before, to increase the sensitivity of IVPA imaging of plaque lipids, a transducer 
covering the low frequency bandwidth (below 8 MHz) should be applied. On the other hand, 
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for a high-resolution IVUS imaging of the artery structure, a high frequency (higher than 20 
MHz) transducer is normally used in the IVPA/US system. To take both the advantages of high 
PA sensitivity for IVPA imaging of plaque and high resolution for IVUS imaging of artery 
wall, an IVPA/US catheter with a dual-element transducer would be an ideal design. Lately, a 
small broadband polyvinylidene difluoride (PVDF) transducer (frequency bandwidth of 2 to 
15 MHz and size of 0.6 × 0.6 mm) with integrated electronics transducer for IVPA imaging 
was developed [33]. It can be potentially integrated into currently available IVPA/US catheter 
for IVPA imaging with more investigation.  
Another possible improvement in our catheter design is to improve the efficiency of light 
delivery for IVPA imaging. In our current catheter, an angle polished fiber covered by a quartz 
cap (at an angle of 37 degree) was used for delivering light to the artery wall, and only about 
40% of the light was delivered out of the fiber. Alternatively, according to our test in the lab, 
a combination of a common multimode fiber and a right angle prism (5 mm leg length) coated 
with the protective silver or gold layer achieved almost 90% of the light delivery. However, 
making the prism small enough to integrate into the miniature IVPA catheter is a challenge.  
6.2.2 Imaging speed 
As most of IVPA/US imaging systems, our current imaging system also requires saline flushing 
for plaque imaging in coronary arteries for a better PA SNR. Especially, when imaging at 1.7 
µm, we used D2O-saline for flushing due to the much lower attenuation of light through D2O. 
Although D2O is non-toxic, it is quite expensive, and can be a limitation for the application of 
IVPA imaging in the future. Moreover, to mitigate risks that may be introduced by the 
disruption to blood flow in the artery, the duration of flushing is limited to only a few seconds, 
leading to a limited volume of artery that can be safely imaged [34]. With a pullback speed of 
0.5 mm/s and continuously saline flushing of maximal 10 s, a maximal 5 mm vessel can be 
safely scanned for one pullback, which is relatively short in practical application. To increase 
the pullback length, a higher pullback speed is recommended. A higher pullback speed 
generally brings in a larger error in longitudinal measurements due to a wider frame pitch 
(pullback speed/frame rate). In consequence, the frame rate should be increased as well. The 
ideal frame rate of IVPA imaging is limited to the highest frame rate of IVUS imaging (around 
100 fps) and it is not possible to increase the frame rate of IVPA imaging freely. The increase 
of the frame rate requires a laser source with a higher pulse rate, which presents as the biggest 
limitation for IVPA imaging at this moment: there is a tradeoff between the high pulse rate for 
high imaging speed and the high pulse energy for high PA SNR, due to the limited optical 
power allowed for tissue imaging and the physical limitations of the laser system. In this case, 
IVPA/US imaging without flushing would be ideal. Principally, it is possible for IVPA imaging 
through the blood at 1.7 µm, which has been achieved in rabbit model ex vivo [35]. In the 
system, very high optical pulse energy is used (1.05 mJ/pulse from the catheter tip), which is 
not practical to use. In terms of IVPA/US imaging in the presence of blood with a reasonable 
laser pulse energy (tens of µJ/pulse), efforts must be taken to optimize the PA sensitivity, light 
delivery and data processing of the imaging system. 
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6.2.3 Other issues 
Other challenges for adapting to the clinical setting, including the cost, robustness, 
compactness and high repetition rate (of the order of 10 kHz) of the laser sources are the topics 
of ongoing research. A new IVPA/US imaging system based on a continuous wave (CW) laser 
instead of a bulky, expensive pulsed laser  proposed recently [36] provides another interesting 
alternative.  
6.2.4 Combination with other imaging modalities 
To capture more presentative features of a vulnerable plaque for a better assessment of the 
plaque lesion, combined imaging modality is a promising approach and may be a future trend 
for intravascular imaging. The combinations of IVUS and NIRS [37], IVUS and IVOCT [38], 
IVOCT and NIRF [39] has been proposed for a better characterization of the vulnerable plaque. 
Superior to NIRS/IVUS, which offers both full visualization of artery wall structure and the 
presence of lipid-rich plaque, IVPA/US imaging shows the lipid-rich plaque with detailed 
depth and volume information. It provides the location of the lipid core related to the lumen 
which is not available in NIRS imaging, and this location information can be critical for making 
the decision of the stenting region in percutaneous coronary intervention (PCI). As a plaque 
close to the lumen, even with a relatively small volume, we may still consider to include it into 
the stent coverage region for a better long-term outcome. Neither the combination of IVUS and 
IVOCT nor IVOCT and NIRF can offer the direct, validated visualization of coronary plaque 
lipid of IVPA imaging.  To many clinicians, the ideal tool for guiding the atherosclerotic plaque 
diagnosis and interventions comprehends high resolution for thin cap thickness 
characterization, high sensitivity to detect lipids for plaque visualization in artery and 
reasonable penetration depth for plaque burden assessment. For that, the combination of 
IVOCT and IVPA would be a very promising choice at the cost of integrating an extra OCT 
laser system.  
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Summary 
 
The rupture of vulnerable atherosclerotic plaque is the most frequent cause of acute 
cardiovascular events and sudden cardiac deaths.  The identification of the vulnerable plaque, 
which is believed to be related to the structure and composition of the plaque, can greatly 
benefit the management of the cardiovascular disease in clinics. A vulnerable plaque is usually 
described as a lipid-rich necrotic core, covered by a thin fibrous cap with macrophage 
infiltration. These common features of the vulnerable plaque can be useful markers for the 
detection of the vulnerable plaque by intravascular imaging techniques. Intravascular 
photoacoustic (IVPA) imaging can characterize the composition of the plaque based on the 
optical contrast between different tissue types, which can be easily applied by performing 
IVPA imaging at different wavelengths for different imaging targets. Combined IVPA/US 
imaging shows great potentials to image the vulnerable atherosclerotic plaque, 
morphologically (co-registered IVUS image) and compositionally (especially lipid-rich 
plaque), and is becoming a powerful tool to guide the assessment and treatment of the 
atherosclerotic plaque lesions.  
The aim of this thesis is to develop a prototype of fast IVPA/US imaging system capable of 
performing in vivo experiments on swine model, accelerating the translation of IVPA/US 
imaging toward clinical application. 
A sensitive, miniature and flexible IVPA/US imaging catheter is critical for the imaging 
system. In chapter 2, we fabricated an imaging catheter with a longitudinal dual beam offset. 
We characterized the imaging property of the catheter in terms of spatial shape of the PSF for 
IVPA imaging in clear and optically scattering media. We showed that the product of the two 
beam profiles can accurately model the measured peak response in clear and scattering media. 
We found that the dual beam offset leads to a curved PSF, making a mismatch between IVPA 
and IVUS imaging planes. Introduction of optical scattering can reduce this mismatch. 
A suitable and effective application of wavelength for IVPA imaging of vulnerable plaque 
(lipid-rich plaque) plays an important role as well. Typically, lipids can be found in the plaque 
inside the artery wall (plaque lipids), as well as in peri-adventitial fat tissue around the artery 
(peri-adventitial lipids), that is present also in normal coronary arteries. In chapter 3, we 
developed an algorithm to detect and differentiate between these two kinds of lipids based on 
the relative difference of the PA signal at 2 wavelengths (1718 and 1734 nm). It achieved about 
70% true positive and 15% false positive identification of plaque lipids in ex vivo human 
atherosclerotic coronary samples. It is possible to be adapted to a different imaging system 
platform by a recalibration of threshold parameter.  
The optimization of PA sensitivity for IVPA imaging of lipid-rich plaque is another significant 
factor. In chapter 4, we investigated ex vivo PA data collected from 35 human atherosclerotic 
plaque lesions and found that majority (80%) of the PA signal power generated from the 
coronary plaque lesions lies in the frequency band below 8 MHz. A match of frequency 
response of the receiving transducer to the low frequency range, below 8 MHz can increase the 
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PA sensitivity of imaging plaque lipid by about 20dB. Our finding makes it possible for IVPA 
imaging of plaque lesions with low laser pulse energy. 
Finally, in chapter 5, we achieved a fast IVPA/US imaging system with a 1.3 mm flexible 
catheter ready for the in vivo application. The imaging system is based on a 5 kHz pulse rate 
OPO laser and allows for IVPA/US imaging at 20 fps, which is 20 times faster than other 
reported systems so far. The capability of the imaging system is validated by a successful ex 
vivo experiment on a human atherosclerotic coronary artery. With this system, we achieved 
the first in vivo IVPA imaging of intracoronary lipid in a swine model with a PA SNR of about 
20 dB. The system operated at 20 fps and 0.1~1 mm/s pullback speed, which is comparable to 
the commercial IVUS imaging system routinely used in clinical practice. It represents a big 
step towards a clinical IVPA/US imaging system, although a lot of future work remains, 
particularly in the optimization of the catheter.  
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Samenvatting 
 
Het scheuren van kwetsbare atherosclerotische plaques is de meest voorkomende oorzaak van 
hartinfarcten. Het herkennen van kwetsbare plaques, kwestbaarheid is gerelateerd aan de 
structuur en de compositie van de plaques, is belangrijk voor de behandeling van hart- en 
vaatziekten. Een kwetsbare plaque wordt gekenmerkt door een necrotische kern met vetten, 
omhuld door een dunne fibreuze kap geïnfiltreerd door macrofagen. Deze vaak voorkomende 
kenmerken van kwetsbare plaques kunnen worden gebruikt voor de detectie hiervan met 
behulp van intravasculaire foto akoestische beeldvormingstechnieken (IPVA). Intravasculaire 
fotoakoestiek beeldvorming kan gebruikt worden om de samenstelling van de plaque vinden 
door middel van optisch contrast tussen verschillende weefsels. Dit kan gemakkelijk worden 
gedaan door IVPA uit te voeren bij verschillende golflengtes van licht voor verschillende 
weefsels. Gecombineerde IVPA en ultrageluid(US) beeldvorming is een veelbelovende 
techniek voor het in beeld brengen van kwetsbare plaques, wat betreft morfologie (co-
geregistreerde IVUS beeld) en samenstelling (specifiek vet rijke plaques). Daarmee is deze 
techniek is een belangrijk middel voor het diagnosticeren en behandelen van atherosclerotische 
plaques.  
Het doel van dit onderzoek is het ontwikkelen van een prototype voor een snel IVPA/US 
beeldvormingssyteem, wat in staat is in vivo experimenten uit te voeren op een varkensmodel, 
en daarmee een versnelling veroorzaken in het vertalen van deze techniek van een onderzoek 
setting naar een klinische toepassing. 
Een gevoelige, kleine en flexibele IVPA/US katheter is essentieel voor het 
beeldvormingssyteem. In hoofdstuk 2 hebben we een beeldvormingskatheter ontwikkeld 
waarbij de optische en akoestische bundels longitudinaal ten opzichte van elkaar geplaatst 
zijn.We hebben de beeldvormingseigenschappen van de katheter gekarakteriseerd wat betreft 
spatiele vorm van de PSF voor IVPA in een helder en optisch verstrooiend medium. We hebben 
aangetoond dat het product van de twee bundel profielen een nauwkeurig model is van de 
gemeten maximale respons in een helder en optisch verstrooiend medium. We hebben 
gevonden dat de duo bundel offset leidt tot een gebogen PSF, wat resulteert in een verkeerde 
overlap tussen de IVPA en IVUS beeldvlakken. Het toevoegen van optische verstrooiing kan 
deze foutieve overlap corrigeren. 
Een geschikte en effectieve toepassing van golflengten voor IVPA beeldvorming van 
kwetsbare plaques (vet rijke plaques) is daarnaast ook een belangrijke factor. Vetten kunnen 
voornamelijk worden gevonden in de plaque, binnenin de vaatwand (plaque vetten), en 
daarnaast ook in peri-adventitieel vet weefsel rondom de slagader (peri-adventitiele vetten), dit 
laatste komt ook voor in normale kransslagaders. In hoofdstuk 3, hebben we een algoritme 
ontwikkeld voor de detectie en differentiatie tussen de twee verschillende soorten lipiden 
gebaseerd op het relatieve verschil tussen het foto akoestische signaal bij twee golflengtes 
(1718 en 1734 nm). Dit algoritme geeft 70% echt positief en 15% vals positieve identificatie 
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van plaque gerelateerde vetten in ex vivo humane atherosclerotische kransslagaders. Het is 
mogelijk om het algoritme aan te passen aan een ander beeldvormingssysteem platform door 
een kalibratie van de parameter drempelwaarde.  
De optimalisatie van foto akoestische gevoeligheid voor IVPA beeldvorming van vet rijke 
plaques is een andere belangrijke factor. In hoofdstuk 4, hebben we gekeken naar ex vivo foto 
akoestische data verkregen van 35 humane atherosclerotische laesies en vonden dat het meeste 
(80%) foto akoestische signaal dat gegenereerd wordt in de coronaire plaque laesies een 
frequentie band heeft beneden 8MHz. De gevoeligheid voor het foto akoestische signaal van 
de plaque vetten kan worden vergroot met 20dB door de frequentierespons van de ultrageluid 
ontvanger te laten overlappen met de uitgezonden frequenties, lager dan 8MHz. Onze 
bevindingen maken het mogelijk om plaque laesies foto akoestische in beeld te brengen met 
lage laser puls energie.  
Tot slot, in hoofdstuk 5, hebben we een snel IVPA/US beeldvormingssyteem ontwikkeld met 
een 1.3 mm flexibele katheter die in vivo gebruikt kan worden. Het systeem is gebaseerd op 
een 5 kHz puls snelheid OPO laser en dit zorgt voor IVPA/US beeldvorming met 20 fps, 20 
keer sneller dan andere gerapporteerde systemen. The mogelijkheden van het systeem zijn 
gevalideerd door een succesvol ex vivo experiment op een humane atherosclerotische 
kransslagader. Met dit systeem hebben we ook de eerste in vivo IVPA beelden van 
intracoronaire vetten in een varkensmodel kunnen vastleggen, met een foto akoestische SNR 
van 20 dB. Het systeem functioneert bij 20 fps en 0.1~1 mm/s terugtrek snelheid, dit is 
vergelijkbaar met commerciële IVUS systemen die routinematig worden gebruikt in de kliniek. 
Dit is een grote stap richting een klinisch toepasbaar IVPA/US systeem, hoewel er nog veel 
werk te verzetten blijft, met name wat betreft het optimaliseren van de katheter.  
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